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Abstract 
Introduction:  Sepsis results in life-threatening organ dysfunction, but if recognised and 
treated promptly, survival chances increase.  Current clinical practice uses the systemic 
inflammatory response syndrome criteria to identify sepsis, and the sepsis six care bundle 
for management.  Changes to the definitions of sepsis internationally and new national 
sepsis guidelines call into question the most appropriate way to recognise and manage 
sepsis.   
Method:  This was a two-site audit of healthcare provider’s compliance to the sepsis six care 
bundle.  All patients admitted to two NHS hospitals over 24 hours were screened for sepsis 
using the modified systemic inflammatory response syndrome criteria and the quick-
sequential (sepsis related) organ failure assessment score.  Adherence was assessed for 
each element of the care bundle for all patients identified with sepsis.   
Results:  249 patients were screened for sepsis; 24 fulfilled the modified systemic 
inflammatory response syndrome criteria for sepsis, and six fulfilled quick-sequential (sepsis 
related) organ failure assessment criteria.  Compliance was poor; only one patient received 
all elements of the sepsis six care bundle.  Three patients (12%) died within 60 days of 
admission; all three were receiving palliative cancer care. 
Conclusion:  Current management of sepsis is below recommended standards.  The 
prevalence of sepsis is different depending upon the screening method used.  
Recommendations for future work include validation of the new sepsis definitions for 
mortality and morbidity rates.  
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1. BACKGROUND 
 
The term sepsis has been in use for thousands of years since the time of Hippocrates and is 
derived from the Greek word sipsi (to make rotten) (1).  In Hippocrates’ time it was related 
to the putrefaction of wounds from infection.  Today, sepsis is defined as a life-threatening 
organ dysfunction caused by a dysregulated host response to infection (2).  It is a syndrome 
rather than a disease, caused by infection, with a wide variety of presentations and 
underlying conditions.  This heterogeneity has made sepsis a difficult syndrome to define, 
leading to controversy over global definitions and inaccuracies in measurements of the 
prevalence of sepsis.  Sepsis recognition by clinicians can be problematic due to the broad 
range of symptoms and signs related to sepsis, leading to delays in treatment and poor 
outcomes.  Even once sepsis has been identified, management varies widely, with 
conflicting evidence surrounding the efficacy of current management guidelines. 
1.1 The pathophysiology of sepsis 
 
The pathophysiology of sepsis and mechanisms of multiple organ system dysfunction are 
complex and involve multiple interacting systems and pathways (3).  The host response to 
sepsis will depend on the causative pathogen, microbial load, virulence of the invading 
micro-organism and the age, genetics and comorbidities of the host (4).  
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1.1.1 The normal physiological response to infection 
 
The host response to infection begins when innate immune cells recognise and bind to 
microbial components (3).  On the surface of host immune cells there are pattern 
recognition receptors (PRRs) that can recognise pathogen-associated molecular patterns 
(PAMPs), such as lipopeptides, peptidoglycan and flagellin (4).  PRRs are categorised 
according to their cellular location and include toll-like receptors (TLRs), nucleotide-
oligomerization domain (NOD)-like receptors and retinoic-acid-inducible gene 1 (RIG-1)-like 
receptors (4).  PRRs also recognise endogenous danger signals (alarmins or danger-
associated molecular patterns, DAMPs) that are released when there is an inflammatory 
insult (4). 
Triggering receptors expressed by myeloid cells-1 (TREM-1) occur on host immune cells 
(neutrophils and monocytes) and amplify the inflammatory cascade in response to infection.  
Co-stimulation of TREM-1 and certain PRRs, especially TLRs, results in a synergistic increase 
in inflammatory signalling (4).  This signalling cascade promotes transcription of genes 
involved in the host inflammatory response, resulting in an increase in pro-inflammatory 
cytokines, chemokines and nitric oxide (5).  Polymorphonuclear leukocytes (PMNs) are 
activated and express adhesion molecules, causing them to aggregate to the vascular 
endothelium (6).  The PMNs migrate to the site of injury, and here they release mediators 
that result in local vasodilatation and increased microvascular permeability (6). 
This process is regulated by pro-inflammatory and anti-inflammatory mediators (6): 
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• Pro-inflammatory mediators include tumour necrosis factor-alpha (TNF-α) and 
interleukin-1 (IL-1), platelet activating factor, interferon and eicosanoids.  They lead 
to the recruitment of more PMNs (4). 
• Anti-inflammatory mediators are cytokines that inhibit the production of TNF-α and 
IL-1 and suppress the immune system by inhibiting cytokine production by 
mononuclear cells and monocyte-dependent T helper cells (4). 
The balance between these mediators regulates adherence, chemotaxis, phagocytosis and 
bacterial killing.  During a successful response to infection the invading microorganism is 
destroyed and tissue repair and healing takes place (6). 
1.1.2 The shift from a normal immune response to sepsis 
 
Sepsis occurs when the immune response to infection becomes dysregulated and the 
equilibrium between pro-inflammatory and anti-inflammatory responses becomes 
unbalanced (figure 1) (4).  There are multiple factors that may lead to dysregulation of the 
host response to infection, including the effects of the micro-organism, release of large 
amounts of pro-inflammatory mediators, complement activation and genetic factors that 
may make some people more susceptible to sepsis (4): 
• Bacterial cell wall components, such as endotoxin, may contribute to the progression 
of infection to sepsis.  Elevated plasma levels of endotoxin are associated with septic 
shock and when endotoxin is infused into humans it reproduces many of the 
features of sepsis, such as activation of the complement, coagulation and fibrinolytic 
systems (7). 
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• Circulating levels of pro-inflammatory mediators, such as TNF-α and IL-1 are 
increased in sepsis and cause induction of other pro-inflammatory cytokines and 
activation of coagulation and fibrinolysis (4). 
• The complement system is a protein cascade that helps to clear pathogens from an 
organism.  The complement system appears to play an important role in sepsis; 
inhibition of the complement cascade decreases inflammation and improves 
mortality in animal models of sepsis (8).  
• The most common form of genetic variation is single nucleotide polymorphism 
(SNP).  These are stable substitutions of a single base that occur more than 1% of the 
time in at least one population and are scattered through the genome.  There are 
many SNPs that are associated with an increased susceptibility to sepsis and include 
SNPs of genes that encode cytokines, cell surface receptors and lipopolysaccharide 
ligands (9). 
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Figure 1 The host response to sepsis.  
Sepsis is characterised by both pro-inflammatory and anti-inflammatory responses.  
Inflammatory responses are initiated by interaction between pathogen-associated molecular 
patterns (PAMPs) or danger-associated molecular patterns (DAMPs) with pattern 
recognition receptors (PRRs) on host immune cells.   
Adapted from: Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate 
immune responses to sepsis. Virulence. 2014;5(1):36-44 (4) 
  
Inflammatory responses initiated 
by interaction between PAMPs or 
DAMPs and PRRs
Pro-inflammtory response 
enhanced by leukocyte, 
complement and coagulation 
activation
Exaggerated inflammation with 
collateral tissue damage and 
necrotic cell death results in 
release of DAMPs and further 
inflammation
Anti-inflammatory immune 
suppressive response dependent 
upon impaired function of 
immune cells, neuroendocrine 
regulation and inhibition of pro-
inflammatory gene transcription
Immune suppression leads to 
enhanced susceptibility for 
secondary infections and late 
mortality
Susceptibility and response to 
sepsis is dependent on host 
factors such as genetic 
composition, age and 
comorbidities and pathogen 
factors such as microbial load and 
virulence
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1.1.3 Cellular injury in sepsis 
 
The dysregulated immune response leads to cellular injury, which in turn leads to organ 
dysfunction.  The mechanism for this is not fully understood, but includes tissue ischaemia, 
cytopathic injury and an altered rate of apoptosis (6). 
 Microcirculatory lesions occur due to the imbalance between the coagulation and 
fibrinolytic systems (3).  Endothelial lesions occur due to the interaction of PMNs with 
endothelial cells (3).  Erythrocytes lose their ability to deform within the systemic 
microcirculation, causing changes to blood flow (3).  All of these changes disrupt tissue 
oxygenation, causing ischaemia, cellular injury and organ dysfunction  (3). 
Pro-inflammatory mediators and other products of inflammation may cause mitochondrial 
dysfunction in sepsis, due to direct inhibition of respiratory enzyme complexes, oxidative 
stress damage and mitochondrial DNA breakdown (10).  This leads to cytotoxicity and cell 
injury (10). 
During sepsis, pro-inflammatory mediators may delay programmed cell death in activated 
macrophages and neutrophils (3).  This leads to a prolongation of the inflammatory 
response.  Concurrently, epithelial cell apoptosis is increased in sepsis, and is associated 
with increased mortality (11). 
1.1.4 Effects of sepsis on organs 
 
The cellular injury that has been described above, in conjunction with the release of pro-
inflammatory and anti-inflammatory mediators, leads to organ dysfunction, commonly 
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affecting multiple organs and systems. 
• Circulation:  Vasodilation due to prostacyclin and nitric oxide release results in 
hypotension.  Impaired compensatory secretion of vasopressin contributes to the 
prolongation of hypotension in sepsis.  Redistribution of intravascular fluid due to 
increased endothelial permeability and reduced arterial vascular tone also results in 
hypotension.  Endothelial dysfunction leads to tissue oedema and micro-particles 
from circulating and vascular cells results in intravascular inflammation (3). 
• Lungs:  Endothelial injury in the pulmonary circulation results in disruption of 
capillary blood flow and an increase in microvascular permeability (3).  This leads to 
interstitial oedema, and due to dysfunction of the alveolar epithelial barrier, this 
fluid then enters the alveoli.  In the microcirculation of the lungs there is neutrophil 
entrapment, and this contributes to further injury of the alveolo-capillary membrane 
(6).  These changes lead to a ventilation-perfusion mismatch, hypoxaemia and 
reduced lung compliance.  The lungs have a large microvascular surface area, and 
therefore a large area for cellular injury due to sepsis; lung injury, manifested as 
acute respiratory distress syndrome (ARDS), often occurs in sepsis (6).  Mechanical 
ventilation of the lungs as a supportive measure in ARDS is in itself associated with 
lung injury, perpetuating inflammation and further injury in sepsis (3). 
• Gastrointestinal tract:  The gut normally acts as a barrier, but in sepsis this is 
compromised due to the circulatory abnormalities that occur, as described 
previously.  This leads to translocation of bacteria and endotoxin into the systemic 
circulation, causing propagation of systemic inflammation and resultant organ 
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dysfunction (3).  There is an association between increasing intestinal permeability in 
sepsis and the development of multiple organ dysfunction; a prospective 
observational cohort study found that a severe derangement of intestinal 
permeability (measured from the urinary fractional excretion of orally administered 
lactulose and mannitol) present on admission to the intensive care unit was 
predictive of subsequent multiple organ dysfunction (natural logarithm of the ratio 
of the fractional urinary excretion of lactulose and mannitol (lnLMR) = -2.0 +/- 1.10 
for patients with multiple organ dysfunction vs. lnLMR = -3.26 +/- 0.83 for patients 
without multiple organ dysfunction) (12). 
• Liver:  In health, the reticuloendothelial system of the liver clears bacteria and 
bacteria-derived products that have entered the portal system from the gut (13).  
Liver dysfunction prevents elimination of endotoxins and bacteria from the gastro-
intestinal tract, which are then able to enter the systemic circulation, leading to 
bacteraemia (13).  In liver dysfunction, the appropriate local cytokine release that 
should occur in response to an invading pathogen is absent, leading to proliferation 
of the pathogenic insult (13).  Liver dysfunction also leads to a concomitant pro-
inflammatory response, with an increase in pro-inflammatory mediators such as 
nitric oxide and TNFα (13).  The liver is integral to metabolic homeostasis and 
coagulation; liver dysfunction in sepsis contributes to coagulopathy and metabolic 
abnormalities (13).  
• Kidney:  Renal injury, as evidenced by a decrease in glomerular filtration rate, is 
common in sepsis and is likely to be due to multiple factors, including degradation of 
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the glycocalyx, tubular epithelial damage and capillary endothelial damage (14).  
Renal failure is associated with an increase in mortality in sepsis (14).  
• Central Nervous System:  Encephalopathy occurs in sepsis and may be due to 
changes in metabolism and cell signalling due to inflammatory mediators.  
Dysfunction of the blood-brain barrier leads to increased leukocyte infiltration, 
exposure to toxic mediators and transport of cytokines across the barrier (15). 
Due to the complexity of the systems involved and the heterogeneity of sepsis, there is 
ongoing research into the pathophysiology of sepsis.  Further understanding of the 
pathophysiology of sepsis will help to guide subsequent management.  
1.2 The global burden of sepsis 
 
Sepsis is now a leading cause of mortality and critical illness across the world (16, 17).  It has 
been estimated that there are 30 million episodes of sepsis and 6 million deaths due to 
sepsis annually worldwide (18).  It’s probable that this is an underestimate of the true 
burden of sepsis, due to a lack of data from low and middle income countries, where 87% of 
the population lives (18).  Hospital coding, where much of the epidemiological data on 
sepsis originates from, will also underestimate the prevalence of sepsis, as many episodes of 
sepsis will be coded as the underlying disease, such as pneumonia or urinary tract infection, 
rather than as sepsis (19).  Other studies have been based in the critical care setting, missing 
patients with sepsis who are treated on the ward (20).  In the UK, conservative estimates on 
the incidence of sepsis are 147,000 per year, but this may be as high as 260,000, costing the 
NHS between £7.76 billion and £11.25 billion a year (21).  Mortality and hospital 
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readmission rates for sepsis are higher than for patients who have had a myocardial 
infarction (22, 23).  Mortality rates for sepsis are estimated to be 10%, increasing to 40% for 
patients with septic shock, compared to a mortality rate of 8.1% for ST elevation myocardial 
infarction (22, 23).  Sepsis accounts for 12.2% of hospital readmissions, compared to 1.3% 
for acute myocardial infarction (23).  The incidence of sepsis continues to rise, which is likely 
to be due to an increasingly ageing population with greater comorbidities, as well as an 
increase in the recognition of sepsis (24).  It is important to establish the prevalence of 
sepsis on both the wards and critical care to be able to understand the extent of the 
problem so that resources, training, and further research can be appropriately targeted 
towards improving outcomes from sepsis.   
In recognition of the global impact of sepsis on patient mortality and morbidity, the World 
Health Assembly (WHA) has adopted a resolution on improving the prevention, diagnosis 
and management of sepsis (25).  In the UK, the National Institute of Health and Care 
Excellence (NICE) has acknowledged the importance of early recognition and treatment of 
sepsis and therefore has released guidelines on the recognition, diagnosis and early 
management of sepsis (26).  These guidelines include recommendations for future research 
on sepsis, and suggest large epidemiological studies to establish the true burden of sepsis 
on the UK healthcare system, as well as auditing the effect of the new NICE guidelines on 
sepsis management in NHS hospitals (26).           
1.3 Diagnosing sepsis 
 
The survival from sepsis can be improved when sepsis is recognised and treated early (24).  
However, sepsis can be difficult to diagnose due to non-specific signs and symptoms, the 
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heterogeneity of infectious diseases that can result in organ dysfunction and the lack of a 
clinical biomarker to identify sepsis (27).  Recent reports from the Parliamentary and Health 
Service Ombudsman and the National Confidential Enquiry into Patient Outcomes and 
Death (NCEPOD) highlight cases of unrecognised sepsis leading to patient morbidity and 
mortality (28, 29), demonstrating the difficulties clinicians face when trying to diagnose 
sepsis.  Overburdened healthcare systems with limited resources and busy staff can also 
contribute to missed or late recognition of sepsis, highlighting additional system-related 
barriers to diagnosing sepsis (30).   
There is evidence that many healthcare professionals lack sufficient knowledge to be able to 
recognise and diagnose sepsis.  One study surveyed ward nurses and found that many of the 
signs and symptoms of sepsis were not recognised by the nurses; only 22% of the nurses 
surveyed recognised that a temperature less than 36°C could be a sign of sepsis (31).  
Another study of paediatric intensive care nurses also demonstrated difficulties in 
recognising the early signs and symptoms of sepsis (32).  Physicians as well as nurses 
struggle to understand the definitions of sepsis, as demonstrated by a Brazilian study that 
found that sepsis was correctly recognised by 27.3% of physicians studied (33).  Although 
these studies focus on small groups of healthcare professionals and were conducted when 
the definition of sepsis was based upon the inflammatory response, they still demonstrate 
the differing levels of knowledge among healthcare professionals.  Educational campaigns to 
improve healthcare professionals’ knowledge of sepsis have been successful, but require on-
going education to sustain knowledge, as a study involving an educational programme to 
promote sepsis care bundles showed a lapse in improvement after one year (34). 
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Healthcare professionals are often able to recognise infection and treat this with 
appropriate antibiotics, but miss the signs and symptoms of organ dysfunction that signify 
that a patient with an infection has sepsis, requiring more supportive care.  Early recognition 
of physiological deterioration can help clinicians to identify patients with sepsis, and the 
Early Warning Score (EWS) was developed to help identify deteriorating patients (35).  
Numerical values are assigned to physiological parameters and a combined score is then 
assigned to the patient, with triggers for escalation of care depending on the score (35).  
Although not specifically designed for patients with sepsis, higher EWS has been found to be 
associated with a greater risk of adverse outcome in patients with sepsis (36).  Data 
collected as part of a national audit from 2003 patients across 20 emergency departments in 
Scotland found that each rise in the national EWS category was associated with an increased 
risk of mortality in comparison to the lowest category (category 4-6: odds ratio OR 1.95; 
95% confidence interval CI, 1.21 -3.14 vs. category 9-20: OR 5.64; 95% CI, 3.70 -8.60) (36).  
However, these scoring systems are only useful if healthcare professionals act on the high 
scores; senior clinical review is mandated and referral to a critical care outreach team may 
be indicated. 
Sepsis diagnosis still proves difficult even when healthcare professional’s knowledge of the 
syndrome is good due to the debate surrounding what actually constitutes sepsis.  Ideally, a 
clinical or biochemical biomarker is needed that can be used as a gold-standard criteria for 
sepsis diagnosis, but currently there are no tests with the required level of sensitivity and 
specificity (27, 37).  The perfect biomarker for sepsis would have fast kinetics, high 
sensitivity and specificity, fully automated technology, a short turn-around time, availability 
as a point-of-care test and low cost (37).  There has been extensive research in this area, 
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aiming to identify early indicators of sepsis or potential predictors of sepsis severity, 
response to therapy and outcome.  A review in 2010 by Pierrakos and Vincent evaluated 
3370 studies that assessed 178 biomarkers.  Despite the wide range of biomarkers studied, 
(including lactate, which is routinely used as a surrogate for organ dysfunction in clinical 
practice) none had sensitivity and specificity greater than 90% for diagnosing sepsis or 
predicting outcome (37).  However, biomarkers could potentially be used to help rule out 
sepsis; Pierrakos and Vincent identified three biomarkers with high negative predictive 
value: procalcitonin, activated partial thromboplastin time and fibrin degradation products.  
However, these studies generally used culture-positive sepsis as the gold standard, yet 
commonly patients with sepsis have negative culture results (37).   
Research in this area is problematic due to the heterogeneity of sepsis; clinical diagnostic 
trials investigating novel biomarkers are methodologically difficult due to a lack of 
consensus over the timing and diagnosis of sepsis using clinical parameters (30).  It is 
unlikely that there is one single biomarker that can reliably diagnose sepsis, but it may be 
possible to have a combination of several biomarkers to accurately diagnose sepsis; further 
research is needed in this area (37).  
1.4 International definitions for sepsis 
 
In order to help with the recognition of sepsis, a consensus was developed in 1991 to agree 
on international definitions for sepsis (38).  Up until 2016 these definitions changed only 
marginally and focussed on the systemic inflammatory response syndrome (SIRS) criteria to 
identify those with sepsis, severe sepsis, or septic shock (SEPSIS-2) (39).  The emphasis of 
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the original definitions was based upon the body’s inflammatory response to infection.  
Sepsis was viewed as a continuum in severity from sepsis through to septic shock.   
1.4.1 The inflammatory response and sepsis 
 
SIRS results from a systemic activation of the innate immune system, and can be caused by 
infection, trauma, thermal injury or sterile inflammatory processes such as acute 
pancreatitis (38).  SIRS is considered to be present when a patient has two or more of any of 
the following clinical findings: a temperature more than 38°C or less than 36°C; a heart rate 
more than 90 beats per minute; a respiratory rate of more than 20 breaths per minute or a 
partial pressure of carbon dioxide in arterial blood of less than 32mmHg or 4.2 kPa; a white 
cell count more than 12000/mm3  or less than 4000/mm3 or more than 10% immature 
bands (table 1) (38). 
The SEPSIS-2 definitions use SIRS as part of the criteria for diagnosing sepsis (table 2).  
However, SIRS lacks specificity and sensitivity to be used as a diagnostic criterion (40, 41).  
Shortly after the introduction of SIRS, one study found that 68% of patients on three 
intensive care units and three general wards had SIRS.  Among these, only 26% developed 
sepsis (40).  Another study has investigated the ability of SIRS to identify infected patients in 
the Emergency Department, and results demonstrated a sensitivity of 69%, and a specificity 
of 35% (41).   
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Table 1 The systemic inflammatory response syndrome 
Two or more of: 
• Temperature more than 38˚C or less than 36˚C 
• Heart rate more than 90 beats per minute 
• Respiratory rate more than 20 breaths per minute or PaCO2 <32 mmHg (4.3 kPa) 
• White blood cell count >12 0 0 0 /mm3 or < 4 0 0 0 /mm 3 or >10% immature 
bands 
A patient is considered to have systemic inflammatory response syndrome (SIRS) if they 
have two or more of any of the signs or investigations listed in the table (38).  ˚C = degrees 
Celsius.  PaCO2 = partial pressure of carbon dioxide in arterial blood.  mmHg = millimetres of 
mercury.  kPa = kilopascals. 
 
 
 
Table 2 Definitions of sepsis 
Consensus Term Definition 
SEPSIS-2 Sepsis SIRS plus documented or suspected infection 
Severe 
Sepsis 
Sepsis complicated by organ dysfunction as defined by Multiple 
Organ Dysfunction Score or Sequential Organ Failure Assessment 
Score ≥ 2 
Septic 
Shock 
Severe sepsis with persistent arterial hypotension despite 
adequate volume resuscitation 
SEPSIS-3 Sepsis 
 
A life-threatening organ dysfunction caused by a dysregulated 
host response to infection 
Septic 
Shock 
A subset of sepsis in which underlying circulatory and 
cellular/metabolic abnormalities are profound enough to 
substantially increase mortality 
The international consensus definitions of sepsis from 2001 (SEPSIS-2) and 2016 (SEPSIS-3), 
including the terms sepsis, severe sepsis and septic shock (2).  SIRS = systemic inflammatory 
response syndrome. 
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1.4.2 Measuring organ dysfunction in sepsis 
 
In 2016 the definitions of sepsis changed (SEPSIS-3), with emphasis moving to organ 
dysfunction rather than the inflammatory response, with the term severe sepsis being made 
redundant; what is now described as sepsis would have been defined as severe sepsis using 
the old definitions (table 2) (2).  The SEPSIS-3 definitions were generated by a task force of 
specialists in critical care, infectious disease, surgery and pulmonary medicine in response to 
an updated understanding of the pathophysiology of sepsis compared to when the first 
definition was agreed over two decades ago (2).  An expert consensus process then settled 
upon updated definitions and clinical criteria for assessing sepsis (2).  Patients can be 
clinically identified as having sepsis (as defined by the new definition) by an acute change of 
two points or more in the sequential (sepsis related) organ failure assessment (SOFA) score 
(2), shown in table 3.  The SOFA score grades abnormality by organ system and takes into 
account any clinical interventions (2).  The higher the SOFA score, the greater the probability 
of mortality (2). 
In addition to the SOFA score, the qSOFA (quick sequential (sepsis related) organ failure 
assessment) score was established as a simple bedside screening tool requiring minimal 
investigations to identify those at high risk of death from sepsis on the wards.  This score is 
made up of three parameters and patients are at high risk of mortality from sepsis when 
two or more of these parameters are present (table 4) (2). 
If a ward patient with a suspected infection has a positive qSOFA score then they should be 
assessed further for evidence of organ dysfunction using the SOFA score.  Using the new 
definitions, septic shock is present when despite adequate fluid resuscitation, vasopressors 
  
17 
 
are required to keep a mean arterial pressure at or above 65mmHg, or the lactate is above 
2mmol/L (2).
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Table 3 The sequential (sepsis related) organ failure assessment score (SOFA) 
A scoring system for the measurement of organ dysfunction (2).  Score 0 – 24; severity of organ dysfunction rises as the score increases.  
**adrenergic agents administered for at least one hour (doses are given in g/kg/minute).  PaO2 = arterial oxygen tension.  FiO2 = fractional 
inspired oxygen.  MAP = mean arterial pressure.  GCS = Glasgow coma score, ranges from 3-15; higher score indicates better neurological 
function.
ORGAN SYSTEM 0 1 2 3 4 
Respiration: 
PaO2 / FIO2 mmHg (kPa) 
> 400 (53.3) < 400 (53.3) < 300 (40) < 200 (26.7) 
(with respiratory support) 
< 100 (13.3) 
(with respiratory support) 
Coagulation: 
Platelets (x 103/µL) 
> 150 < 150 < 100 < 50 < 20 
Liver: 
Bilirubin (mg/dL)  
 
< 1.2 
 
1.2 – 1.9 
 
2.0 – 5.9 
 
6.0 – 11.9 
 
> 12.0 
 (mol/L)  <20 20 - 32 33 - 101 102 - 204 >204 
Cardiovascular: 
Hypotension  
No 
hypotension 
MAP < 70 
mmHg 
**dopamine < 5.0 
 or any dose 
dobutamine 
**dopamine 5.1-15 or 
adrenaline  0.1 or 
noradrenaline  0.1  
**dopamine > 15  
or adrenaline >0.1 
or noradrenaline >0.1 
Renal: 
Creatinine (mg/dl)  
 
< 1.2 
 
1.2 – 1.9 
 
2.0 – 3.4 
 
3.5 – 4.9 
 
> 5.0 
(mol/L) < 110 110-170 171-299 300-440 > 440 
OR Urine output    or < 500 ml/day or < 200 ml/day 
Neurological: GCS 15 13-14 10-12 6-9 < 6 
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Table 4 The qSOFA score 
Two or more of: 
• Respiratory rate of 22 breaths per minute or more 
• Altered mentation 
• Systolic blood pressure < 100mmHg 
The quick sequential (sepsis related) organ failure assessment score is a simple bedside 
screening tool to identify those patients at high risk of mortality from sepsis (2).  If any two 
of the three parameters are present, this suggests that the patient has an increased risk of 
death from sepsis in the ward setting. 
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1.4.3 Controversy surrounding the new sepsis definitions 
 
There has been significant debate about the validity of these new definitions compared to 
the older SIRS-based definitions of sepsis (42, 43).  There is concern that although helpful to 
evaluate the epidemiology and economic burden of sepsis, it will not be helpful in the 
clinical setting when treating individual patients who will vary widely due to the underlying 
cause of their sepsis, and the heterogeneity of the sepsis syndrome (43).   
In addition to concerns over the definitions, there is debate surrounding the use of SOFA 
and qSOFA to identify patients with sepsis (43).  The SOFA score is more complex than using 
SIRS and requires sequential use to identify a change in the score.  This means that in the 
clinical setting it is only accurate once sepsis has already been present for some time (the 
baseline SOFA score is presumed to be zero if the patient has not been scored previously), 
and only critical care patients will have all aspects of the scoring system measured 
frequently.   
The SOFA and qSOFA scores were validated using retrospective data from the United States 
(US) that compared SIRS, SOFA, qSOFA and the Logistic Organ Dysfunction System (LODS), a 
weighted organ dysfunction score (42).  These data were taken from 1.3 million electronic 
health record encounters between the 1st January 2010 and 31st December 2012 at 12 
hospitals in Pennsylvania in the US.  Patients who were identified with suspected infection 
were included in analysis.  Suspected infection was identified as the combination of 
antibiotics and body fluid cultures (42).  This study found that within the intensive care unit 
(7932 patients with suspected infection), the predictive validity of SOFA (area under the 
receiver operating characteristic curve (AUROC) = 0.74; 95% CI, 0.73-0.76; P < 0.001) for in-
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hospital mortality was statistically greater than SIRS (AUROC = 0.64; 95% CI, 0.62-0.66; P < 
0.001) or qSOFA (AUROC = 0.66; 95% CI, 0.64-0.68; P < 0.001).  SOFA and LODS (AUROC = 
0.75; 95% CI, 0.73-0.76; P < 0.001) had similar predictive validity, but LODS is a more 
complex scoring system than SOFA, leading to SOFA being recommended for use in the 
intensive care setting when assessing a patient for sepsis (42).  On the wards (66522 
patients with suspected infection), qSOFA (AUROC = 0.81; 95% CI, 0.80-0.82; P < .001) was 
found to have statistically greater predictive validity for in-hospital mortality than SIRS 
(AUROC = 0.76; 95% CI, 0.75-0.77; P < 0.001) and SOFA (AUROC = 0.79; 95% CI, 0.78-0.80; P 
< 0.001), leading to its adoption for use in the ward setting to identify patients at risk of 
death from sepsis (42).   
Further studies since the publication of the new definitions have attempted to validate the 
new scoring systems.  A study of 152 patients in the US retrospectively compared qSOFA 
and SIRS in patients admitted to hospital with suspected sepsis who were later admitted to 
ICU (44).  It found that qSOFA was statistically better at predicting in-hospital mortality than 
SIRS (AUROC = 0.74; 95% CI, 0.66-0.81 vs. AUROC = 0.59; 95% CI, 0.51-0.67; P = 0.03) (44).  
This cohort only included patients who were admitted to ICU.  The results could potentially 
have been different if patients who were only managed in the ward setting were included. 
Another retrospective study in Australia and New Zealand analysed the predictive validity of 
SOFA, qSOFA and SIRS in the intensive care setting in 184,875 patients, and as found in the 
original study on validation, SOFA score was found to have significantly better predictive 
validity (AUROC = 0.753; 95% CI, 0.750-0.757; P<0.001) for in-patient mortality than either 
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SIRS (AUROC = 0.589; 95% CI, 0.585-0.593; P < 0.001) or qSOFA (AUROC = 0.607; 95% CI, 
0.603-0.611; P < 0.001) (45).   
However, the SOFA and qSOFA scores have not been validated within the UK healthcare 
setting, and only one European study of 879 patients has used prospective data to validate 
the use of qSOFA for the identification of patients at high risk of mortality from sepsis (46).  
This study found that the qSOFA score performed better than SIRS in predicting in hospital 
mortality (AUROC = 0.80; 95% CI, 0.74-0.85 vs. AUROC = 0.65; 95% CI, 0.59-0.70; P < 0.001) 
(46).  This study only included patients in the emergency department, limiting the 
generalisability of the results.   
All of the studies described used in-hospital mortality as an end-point, as this was the end-
point used by Seymour et al to originally validate the SOFA and qSOFA scores (42).  
Prediction of longer term mortality cannot be assessed from these studies, yet is relevant as 
patients who survive an episode of sepsis in hospital have increased risk of mortality and 
morbidity for a prolonged time period (47, 48).  A prospective study in Wales used 30 day 
mortality as its end point, and was unable to validate the use of qSOFA to predict mortality 
(49).  This study screened patients for sepsis who had a National Early Warning Score 
(NEWS) of 3 or more.  Out of the 5422 patients screened, 431 had a NEWS score of 3 or 
more and 380 of these were recruited into the study.  SOFA was found to be best at 
predicting mortality risk (AUROC = 0.69; 95% CI, 0.63-0.76; P < 0.001), followed by NEWS 
(AUROC = 0.58; 95% CI, 0.51-0.66; P < 0.001), but SIRS (AUROC = 0.55; 95% CI, 0.49-0.61) 
and qSOFA (AUROC = 0.56; 95% CI 0.49-0.64) were unable to predict outcome in this cohort 
(49).  This is quite different from the retrospective results presented by other studies, and 
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questions whether qSOFA should be used as a tool to predict mortality from sepsis on wards 
in the UK healthcare setting.  It is possible that the results differ due to the use of 30 day 
mortality rather than in-hospital mortality.  It is also possible that the study by Szakmany et 
al missed patients by only screening patients with a NEWS score of 3 or more, which may 
have affected their results (49).   
A summary of studies assessing the predictive validity of sepsis criteria can be found in table 
5. Further research is needed to assess whether clinicians in the UK should adopt the use of 
the new definitions and their scoring systems when assessing patients with suspected 
sepsis.  
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Table 5 Summary of studies assessing predictive validity of sepsis criteria 
Study Study type Setting Number of 
patients 
Primary 
outcome 
Criteria validated Crude AUROC values 
(95% CI) 
P value 
Raith and 
coleagues (45) 
Retrospective 
cohort 
Australia and 
New Zealand 
184875 In-hospital 
mortality 
SOFA 0.753 (0.750-0.757) P<0.001 
qSOFA  0.607 (0.603-0.611) 
SIRS 0.589 (0.585-0.593) 
Seymour and 
colleagues (42) 
Retrospective 
cohort 
Pennsylvania 148907 In-hospital 
mortality 
SOFA 0.74 (0.73-0.76) P<0.001 
qSOFA 0.66 (0.64-0.68) 
SIRS 0.64 (0.62-0.66) 
LODS 0.75 (0.73-0.76) 
Finkelsztein and 
colleagues (44) 
Retrospective 
cohort 
New York 152 In-hospital 
mortality 
qSOFA 0.74 (0.66-0.81) P=0.03 
SIRS 0.59 (0.51-0.67) 
Freund and 
colleagues (46) 
Prospective 
cohort 
Europe 879 In-hospital 
mortality 
qSOFA 0.80 (0.74-0.85) P<0.001 
SIRS  0.65 (0.59-0.70) 
Szakmany and 
colleagues (49) 
Prospective 
cohort 
Wales 380 30-day 
mortality 
SOFA 0.69 (0.63-0.76) P<0.001 
qSOFA 0.56 (0.49-0.64) 
SIRS 0.55 (0.49-0.61) 
NEWS 0.58 (0.51-0.66) 
A table summarising the findings of studies examining the predictive validity of sepsis criteria, including SIRS (systemic inflammatory response 
syndrome), SOFA (sequential (sepsis related) organ failure assessment score), qSOFA (quick sequential (sepsis related) organ failure 
assessment score), LODS (logistic organ dysfunction system) and NEWS (national early warning score).  Crude AUROC and P values are 
demonstrated for each main study finding related to the study’s primary outcome.
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1.5 NICE guidelines on sepsis recognition and diagnosis 
 
Although the NICE guidelines on sepsis recognition, diagnosis and early management have 
acknowledged the new definitions of sepsis, it has stated that these definitions are not 
useful in the early identification of people at risk of sepsis (26).  NICE endorses actions 
according to clinical parameters that stratify risk of severe illness or death from sepsis.  As a 
result of this, NICE recommendations do not use either SIRS or SOFA criteria to identify 
patients with suspected sepsis.  Instead there is a comprehensive list of signs, symptoms 
and risk factors to identify patients at low, moderate or high risk of sepsis.  This strategy is 
likely to identify more patients “at risk” of sepsis than either the SIRS or SOFA criteria, 
although the aim of this risk stratification is similar to that of the qSOFA score.  The NICE risk 
stratification criteria are far more comprehensive than the three parameters used in the 
qSOFA score, which may help to ensure that high risk patients are not missed, but may also 
result in more false positives (table 6) (26).  The NICE stratification system is not as user 
friendly as the qSOFA score, which may result in clinicians being reluctant to use it. 
A study conducted at Heartlands Hospital in Birmingham retrospectively reviewed the notes 
of 415 consecutive patients who presented to the acute medical unit.  Twenty per cent of 
patients were identified with sepsis using the SIRS criteria, 33% had sepsis according to NICE 
criteria, and 4% were positive for the qSOFA score (51).  This demonstrates in this cohort the 
large number of patients identified with sepsis by NICE guidelines.  This study also 
attempted to assess the sensitivity and specificity for sepsis of the different systems used to 
identify sepsis by comparing to a consultant’s clinical impression of sepsis (51).  NICE 
guidelines were less specific but more sensitive than qSOFA, however a comparison against 
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one clinician’s opinion of what constitutes sepsis is an inaccurate method to use as a gold 
standard. 
Research is needed to assess the validity of NICE guidelines in diagnosing suspected sepsis 
and identifying those at highest risk of mortality from sepsis, and the impact of the 
guidelines on patient outcomes. 
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Table 6 NICE risk stratification tool for adults, children and young people aged 12 years and over with suspected sepsis 
Category  High risk criteria Moderate to high risk criteria Low risk criteria 
History Objective evidence of new altered 
mental state 
History from patient, friend or 
relative of new onset of altered 
behaviour or mental state 
History of acute deterioration of 
functional ability 
Impaired immune system 
(illness or drugs including oral 
steroids) 
Trauma, surgery or invasive 
procedures in the last 6 weeks 
Normal behaviour 
Respiratory Raised respiratory rate: 25 breaths 
per minute or more 
New need for oxygen (more than 
40% FiO2) to maintain saturation 
more than 92% ( or more than 88% 
in known chronic obstructive 
pulmonary disease) 
Raised respiratory rate: 21-24 
breaths per minute 
No high risk or moderate to high 
risk criteria met 
Blood pressure Systolic blood pressure 90mmHg or 
less or systolic blood pressure more 
than 40mmHg below normal 
Systolic blood pressure 91-
100mmHg 
No high risk or moderate to high 
risk criteria met 
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Category  High risk criteria Moderate to high risk criteria Low risk criteria 
Circulation and hydration Raised heart rate: more than 130 
beats per minute 
Not passed urine in previous 18 
hours 
For catheterised patients, passed 
less than 0.5ml/kg of urine per hour 
 
Raised heart rate: 91-130 beats 
per minute (for pregnant 
women 100-130 beats per 
minute) or new onset 
arrhythmia 
Not passed urine in the past 12-
18 hours 
For catheterised patients, 
passed 0.5-1ml/kg of urine per 
hour 
No high risk or moderate to high 
risk criteria met 
Temperature  Tympanic temperature less than 
36˚C 
 
Skin Mottled or ashen appearance 
Cyanosis of skin, lips or tongue 
Non-blanching rash of skin 
Signs of potential infection, 
including redness, swelling or 
discharge at surgical site or 
breakdown of wound 
No non-blanching rash 
A tool developed by NICE (the national institute for health and care excellence) to help stratify a patient’s risk of mortality from sepsis into low, 
moderate to high, or high-risk criteria (26).  Criteria are taken from the patient’s history, examination and vital signs.  FiO2 = fraction of 
inspired oxygen.  mmHg = millimetres of mercury.  ˚C = degrees Celsius
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1.6 Management of sepsis 
 
Once sepsis has been recognised, prompt management can help decrease the mortality 
from sepsis (29).  The Surviving Sepsis Campaign has devised international guidelines for the 
management of sepsis and septic shock (52).  These guidelines were most recently updated 
in 2016 from the 2012 guidelines.  A summary of the recommendations for the initial 
management of sepsis can be found in table 7 (52).  A consensus committee of 55 
international experts on sepsis convened to develop these guidelines.  The committee 
searched for the best available evidence on sepsis management, and assessed the quality of 
the evidence using the Grading of Recommendations Assessment, Development and 
Evaluation (GRADE) system (52).  This resulted in 93 statements on the early management 
and resuscitation of patients with sepsis and septic shock.  Thirty-two of these were strong 
recommendations, 39 were weak recommendations, 18 were best-practice statements and 
there were no recommendations for four of the statements, demonstrating that there is 
substantial agreement amongst experts on the management of sepsis (52).  However, there 
is controversy over the use of care bundles derived from the Surviving Sepsis Campaign 
Guidelines (SSCG) for the management of sepsis, due to low compliance rates and 
conflicting data on patient outcomes (53).   
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Table 7 Recommendations from the surviving sepsis campaign guidelines on initial sepsis 
management 
Recommendation Level of evidence/recommendation 
In sepsis–induced hypoperfusion, 30ml/kg 
of IV crystalloid fluid should be given within 
the first 3 hours 
Low quality evidence, strong 
recommendation 
An initial target mean arterial pressure of 
65mmHg in patients with septic shock 
requiring vasopressors 
Moderate quality evidence, strong 
recommendation 
Guide resuscitation to normalise lactate in 
patients with elevated lactate levels 
Low quality evidence, weak 
recommendation 
Appropriate routine microbiologic cultures 
obtained before starting antimicrobial 
therapy in patients with suspected sepsis 
as long as there is no delay in starting 
antimicrobials 
Best practice statement 
Administration of IV antimicrobials within 
one hour of recognition of sepsis 
Moderate quality evidence, strong 
recommendation 
Identify source of infection as rapidly as 
possible and implement source control as 
soon as possible 
Best practice statement 
Norepinephrine as the first choice 
vasopressor 
Moderate quality evidence, strong 
recommendation 
A summary of recommendations from the Surviving Sepsis Campaign Guidelines related to 
the initial management of sepsis, with the associated level of evidence and 
recommendation listed for each recommendation (52).  IV = intravenous.  mmHg = 
millimetres of mercury. 
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1.6.1 Early goal directed therapy in sepsis 
 
Early goal directed therapy (EGDT) is a 6 hour resuscitation algorithm where therapy is 
guided by optimisation of haemodynamic goals targeting arterial blood pressure, central 
venous pressure and central venous oxygenation saturation (54).  A single centre 
randomised trial in 2001 of 263 patients presenting to the emergency department with 
septic shock found that EGDT decreased short-term mortality compared to standard care (in 
hospital mortality 30.5% in EGDT group vs. 46.5% in the standard therapy group, P = 0.009) 
(54).  This led to the Surviving Sepsis Campaign endorsing EGDT in 2004, but compliance was 
poor and further trials failed to show any improvement in survival when patients were 
treated with EGDT.   
A multi-centre randomised trial of 1341 patients in the United states on the Protocolized 
Care for Early Septic Shock (ProCESS study) found that there was no significant difference in 
mortality when patients were managed either by protocol-based EGDT, protocol-based 
standard therapy or usual care (relative risk with protocol-based therapy vs. usual care, 
1.04; 95% CI 0.82-1.31; P = 0.83; relative risk with protocol based EGDT vs. protocol-based 
standard therapy 1.15; 95% CI 0.88-1.51; P = 0.31) (55).   
An Australasian study (the Australasian Resuscitation in Sepsis Evaluation (ARISE) study) of 
1600 patients across 51 centres also found that EGDT did not reduce all-cause mortality at 
90 days compared to usual care (absolute risk difference with EGDT vs. usual care, -0.3 
percentage points; 95% CI -4.1 to 3.6; P = 0.9) and also demonstrated that patients in the 
EGDT group received a larger mean volume of intravenous fluids (1964ml vs. 1713ml) in the 
first 6 hours after randomisation compared to the usual care group and were more likely to 
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receive vasopressor infusions (66.6% vs. 57.8%), red-cell transfusions (13.6% vs. 7%) and 
dobutamine (15.4% vs. 2.6%) (P < 0.001 for all comparisons) (56).   
A third multi-centre study in the UK (the protocolised management in sepsis (ProMISe) 
study, which completed the trio of studies on EGDT) of 1260 patients also found no 
significant difference in 90-day mortality between patients managed using EGDT and 
patients managed using usual resuscitation (absolute risk reduction −0.3%, 95% CI −5.4 to 
4.7; relative risk 1.01, 95% CI 0.85 to 1.20; P = 0.9) (57).   
A meta-analysis of 11 randomised controlled trials, including the ProCESS, ARISE and 
ProMISe multi-centre trials, demonstrated no significant difference in mortality yet an 
increase in the use of intensive care resources (increased vasopressor use and increased ICU 
admission) with EGDT compared to standard care. (58).  It is possible that the lack of survival 
benefit is related to an overall increased standard of care in hospitals treating patients with 
sepsis compared to management in 2001.  However, it does highlight the pitfalls of using a 
bundled approach to sepsis management. 
1.6.2 The sepsis six care bundle 
 
Hospitals in England and Wales have adopted the use of the one hour sepsis six care bundle 
for the management of patients with suspected sepsis.  The sepsis six care bundle is a 
bundle of six interventions designed to improve patient outcomes when completed within 
one hour of sepsis being identified in a patient (table 8) (22).   
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Table 8 The sepsis six care bundle 
Give high-flow oxygen via non-rebreathe 
bag 
Take blood cultures and consider source 
control 
Give IV antibiotics according to local 
protocol 
Check lactate 
Start IV fluid resuscitation e.g. Hartmann’s 
or equivalent 
Monitor hourly urine output and consider 
catheterisation 
The six elements of the sepsis six care bundle, which has been adopted by hospitals in 
England and Wales for the initial management of sepsis (22).  All six steps of the bundle 
should be completed within one hour of recognition of sepsis. IV = intravenous. 
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Care bundles were developed by the Institute for Health Care Improvement (IHI) and are 
small collections of evidence-based tasks, that when implemented together should achieve 
better outcomes than when instigated individually (53).  Bundles are designed by selecting 
interventions with the greatest benefit to be included in the bundle.  However, this means 
that not all potentially beneficial interventions will be included, and there is a lack of peer 
reviewed data to support the assertion that better outcomes are achieved when bundles 
are used (53).   
Sepsis care bundles have generated controversy for over a decade, with concerns over 
implementation and absence of supportive evidence (53).  Despite its widespread 
application across England and Wales, evidence on the efficacy of the sepsis six care bundle 
is lacking.  Since the establishment of the one-hour sepsis six care bundle in 2007, there has 
been limited data on compliance rates with the bundle, and studies related to the impact of 
the care bundle on mortality rates show conflicting results.  A prospective observational 
cohort study conducted when the bundle was initially established showed that out of 567 
patients with severe sepsis, 36.6%  received the bundle, with a mortality rate of 20%, 
compared to 44.1% for patients who did not receive the care bundle (22).   In an 
observational study in Wales of 2716 acute admissions in 2015, of the 51 (1.9%) patients 
diagnosed with sepsis only three (6%) received the full sepsis six care bundle within one 
hour (59).  No mortality data were collected from this study. 
A multicentre, prospective observational study in Wales of 1,111 patients found that 
completion of the full sepsis six care bundle occurred in 12% of patients with sepsis (60).  
This study found no significant difference in mortality related to the delivery of the sepsis six 
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care bundle (60).  A quality improvement project in a busy Emergency Department in the UK 
demonstrated an improvement in mortality rates when compliance to the sepsis six care 
bundle was improved (61), yet another quality improvement project set in a UK district 
general hospital showed no significant difference in mortality rates despite an increase in 
adherence to the sepsis six care bundle (62).  Both of these quality improvement projects 
involved small numbers of patients and included several quality improvement initiatives 
that had the potential to improve overall patient care even when the sepsis six care bundle 
was not adhered to, possibly confounding the mortality rate results. 
The large reduction in patient mortality observed in the first study when the bundle was 
originally established has not been replicated in any other studies (22).  The original study 
was observational and involved small numbers and was unable to control adequately for 
confounding factors.  The study was also performed at the same time as an educational 
campaign at the hospital to highlight sepsis and its management.  It could be that the 
improvement in mortality was related to an overall higher standard of care related to 
increased clinician awareness of sepsis due to the educational programme, rather than a 
direct impact of the bundle.  Furthermore, a breakdown of compliance to individual 
elements of the bundle showed a significant reduction in mortality for taking blood cultures, 
giving fluids and giving antibiotics, and not for the other three bundle interventions (22).  
This suggests the importance of certain elements of the management of sepsis, such as 
giving intravenous antibiotics, rather than the importance of a bundle of care as a whole.   
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1.6.3 NICE guidelines on early sepsis management 
 
The current NICE guidelines on sepsis management have moved away from the one hour 
sepsis six care bundle, although elements of the care bundle that are evidence based are 
included, such as obtaining blood cultures prior to the administration of antibiotics (26).  
However, other elements of the care bundle have been modified, such as only giving oxygen 
to those who need it to maintain oxygen saturations at an appropriate level, conceding to 
evidence of the potential detrimental effects of hyperoxia (63).  The NICE guidelines on 
sepsis management are more complicated than the sepsis six care bundle, and involve 
different management depending on the risk stratification level of the patient.  These 
management guidelines are more tailored to individual patients than the sepsis six care 
bundle, and respond to changes in the patient’s condition, making it more dynamic than the 
care bundle.  The downside of this is an increase in complexity of management that may 
result in poor compliance to the guidelines.  As the guidelines have only recently been 
implemented, there is currently no published data on adherence to the NICE guidelines, or 
patient outcomes following instigation of the guidelines. 
1.6.4 Timing of sepsis management 
 
As well as concerns over the efficacy of sepsis care bundles, there is a lack of consensus over 
timing of the management of sepsis.  The sepsis six care bundle should be delivered within 
one hour of identifying a patient as having sepsis (or within one hour of admission to 
hospital if they are admitted with sepsis).  NICE guidelines recommend the treatment and 
review of patients at high risk of sepsis within one hour (26) and NHS England 
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Commissioning for Quality and Innovation (CQUIN) national goals include the administration 
of antibiotics within 60 minutes of a patient being diagnosed with sepsis (64).   
A study in New York state of 49,331 patients at 149 hospitals has demonstrated lower 
mortality for patients who received a bundle of care (intravenous antibiotics, blood cultures 
and lactate measurement) within three hours of arrival in the emergency department (65).  
This retrospective study analysed data routinely collected between 2014 and 2016, after 
New York began requiring hospitals to follow protocols for the early identification and 
treatment of sepsis in 2013.  The study found that each additional hour of time to 
completion of the 3 hour bundle was associated with higher mortality (odds ratio of death 
until completion of the 3-hour bundle, 1.04 per hour; 95% CI, 1.02-1.05; P < 0.001) (65).  
Patients who had the bundle completed anytime between 3 and 12 hours had an even 
higher risk of in-hospital death (OR 1.14; 95% CI, 1.07 to 1.21; P < 0.001) (65).   
There is also evidence that administering antibiotics within one hour decreases mortality, 
and that every hour delay shows a stepwise drop in survival (66).  A retrospective cohort 
study of 2,731 patients with septic shock found that administration of antibiotics within the 
first hour of documented hypotension was associated with a survival rate of 79.9% (66).  
Each hour of delay over the next 6 hours was associated with an average decrease in 
survival of 7.6%.  This study used retrospective data between 1989 and 2004, before the 
implementation of sepsis care bundles, and only focussed on patients with septic shock.   
A more recent cohort study performed between 2005 and 2006 studied the association 
between time to antibiotic administration and survival in 261 patients with severe sepsis 
and septic shock who underwent early goal directed therapy (67).  This study found that 
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mortality was decreased when antibiotics were administered within 1 hour from triage 
(19.5% vs 33.2%; odds ratio, 0.30; 95% CI 0.11-0.83; P = 0.2).  The results from this study are 
from a smaller cohort at a single-centre in patients managed using early goal directed 
therapy, making these results less generalisable.   
A larger retrospective analysis of 17,990 patients with severe sepsis or septic shock in ICUs 
in Europe, the United States and South America between 2005 and 2010 found a significant 
increase in the probability of death associated with delay in antibiotic administration (68).  
Hospital mortality increased from 32% for patients given antibiotics within 1 hour to 39.6% 
for patients who didn’t receive antibiotics for over 6 hours (P < 0.001).  However, a meta-
analysis of studies investigating timing of antibiotic administration and mortality in severe 
sepsis and septic shock found no significant mortality benefit in administering antibiotics 
within three hours of emergency department triage or within one hour of identifying shock 
(69).  This meta-analysis pooled data from 11 studies conducted between 1989 and 2012.  
There are several potential reasons why the meta-analysis found no mortality benefit.  It 
could be that the complexity of sepsis means that a single factor such as one dose of 
antibiotics is unable to have a significant impact on survival (69).  It could also be possible 
that resuscitation of patients prior to the administration of antibiotics improves survival, 
confounding the results (69).  The use of emergency department (ED) triage time as the 
start point for administration of antibiotics could also confound results, as many patients do 
not meet the diagnostic criteria for severe sepsis and septic shock until after triage time 
(69).  None of the studies were randomised controlled trials due to the difficulty in 
conducting such a study, and this may also have confounded the results of the meta-
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analysis.  Overall, it seems logical to administer antibiotics as early as possible in sepsis, but 
the exact timing of antibiotics as a measure of the quality of care in sepsis remains unclear.   
In addition to this, logistically and practically it can be challenging to deliver the sepsis six 
care bundle within one hour.  An ethnographic study in six hospitals participating in the 
Scottish Patient Safety Programme Sepsis Collaborative conducted 300 hours of observation 
in emergency departments, acute medical units and medical and surgical wards, and 
interviewed 43 members of staff (70).  This study identified that although the bundle first 
appears to be only six simple steps, it is actually a complex process involving multiple 
interdependent tasks.  For example, giving IV antibiotics involves finding a doctor to 
prescribe the antibiotic, obtaining IV access, finding a nurse with IV certificate to prepare 
the medication before finally administering the antibiotic (70).  The study found that this 
required significant input from several different members of staff, who also had competing 
tasks that meant that they could not always prioritise completion of the sepsis six care 
bundle (70).  As this ethnographic study was only conducted in hospitals in Scotland, it could 
be that these barriers to implementation are specific to the Scottish healthcare system.  
However, it is likely that hospitals in England and Wales face similar issues, highlighting the 
complexity of healthcare delivery.     
1.7 Summary of the limitations of current research 
Currently, our improved knowledge of the pathophysiology of sepsis has led to the 
development of new definitions and diagnostic criteria for sepsis and updated guidelines on 
the management of sepsis.  However, there is limited evidence to validate the use of the 
new sepsis diagnostic criteria in the UK healthcare setting, and the recent implementation 
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of new management guidelines means that it is too early to assess the impact of these 
guidelines on sepsis outcomes. 
Changes to the definitions of sepsis, the lack of research and poor data collection will mean 
that the prevalence of sepsis is likely to significantly change over the coming years.  
Despite its long-term implementation, the sepsis six bundle has been shown to have poor 
compliance rates and unclear efficacy on sepsis mortality rates (53, 59-62).  With the 
implementation of new criteria to define, diagnose and manage sepsis, it is unclear what 
impact this may have on compliance to the sepsis six bundle and sepsis mortality outcomes. 
This project aims to address some of these knowledge gaps:  
• the current compliance rates to the sepsis six bundle following implementation of 
new sepsis diagnostic criteria and management guidelines (whilst the sepsis six 
bundle is still in use) 
• the prevalence of sepsis in new hospital admissions using a modified SIRS diagnostic 
criteria and the new qSOFA criteria for sepsis 
• the impact of sepsis management on mortality rates of patients identified with 
sepsis. 
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2. AUDIT OF COMPLIANCE TO THE 
SEPSIS SIX BUNDLE 
 
2.1 Aims of the audit 
 
The aims of the audit were to: 
1. Assess healthcare providers’ compliance to the sepsis six care bundle in two acute 
NHS Hospitals when managing patients admitted to hospital over a 24-hour period 
who fulfil the diagnostic criteria for sepsis. 
2. Investigate the prevalence of sepsis in new adult hospital admissions over a 24-hour 
period using a modified SIRS criteria for sepsis and the qSOFA score. 
3. Assess in-hospital, 30-, 60- and 90-day mortality rates of patients included in the 
audit. 
2.2 Objectives of the audit 
 
The objectives of the audit were to: 
1. Determine standards of practice for the management of sepsis at two NHS hospitals 
and consider whether healthcare providers’ compliance to the sepsis six care bundle 
when treating patients with sepsis is comparable between the two hospitals. 
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2. Find out whether the prevalence of sepsis amongst new hospital admissions differs 
depending upon the criteria used for the diagnosis of sepsis (modified SIRS or 
qSOFA). 
3. Determine whether mortality rates for sepsis are influenced by the level of 
compliance with the sepsis six care bundle.   
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3. METHODOLOGY 
 
3.1 Ethical considerations 
 
This was an audit, defined as an assessment of compliance with a recognised standard of 
care.  It did not involve any interventions, patient contact or collection of patient 
identifiable data, therefore requirement of ethical approval was waived, as demonstrated 
by the Health Research Authority (HRA) decision tool (71).  The audit protocol was reviewed 
and approved as audit by both the local research and development and audit departments 
of the participating hospital trusts.   
3.2 Patient and public involvement (PPI) 
 
The audit protocol was discussed with the local Patient and Public Involvement (PPI) group 
who scrutinised and approved the final audit objective, design and outcome measures.  The 
PPI group, called the Clinical Research Ambassador Group (CRAG) were involved from 
inception of the audit, and offered feedback on the audit design.  The PPI group were 
interested in finding out the impact of patient care on patient deaths and suggested finding 
out mortality rates of the patients included in the audit.  This was felt to be a valid query 
and was therefore added to the final audit protocol. 
3.3 Location and time of audit 
 
Data collection took place on Wednesday 22nd June 2016 at two large university affiliated 
acute hospitals in the West Midlands:  Birmingham Heartlands Hospital (BHH) and 
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University Hospital Birmingham (UHB).  At the time of the audit, BHH was part of the Heart 
of England NHS Foundation Trust (HEFT), one of the largest NHS trusts in England, serving a 
population of 1.2 million.  BHH is located in Bordesley Green in Birmingham and provides 
care for a diverse population across Birmingham East and North.  It has 692 in-patient beds, 
including 12 level 3 beds.  UHB is located in Edgbaston in Birmingham and is a large tertiary 
hospital, treating over 1 million patients in 2016.  It has 1213 inpatient beds, 32 operating 
theatres and a 100-bed critical care unit and is the largest single site hospital in England.  
The medical teams at each hospital site were informed of the audit when data collection 
took place.  The medical teams were the health care professionals working in each ward 
during data collection who were responsible for the clinical care of the patients included in 
the audit.  Data were collected by a team independent of clinical delivery.   
3.4 Inclusion criteria 
 
All adult acute admissions between 00:00 and 23:59 on 22nd June 2016 were eligible.  Based 
upon average daily hospital admission rates it was expected that around 270 patients would 
be screened for sepsis.   
3.5 Exclusion criteria 
 
Patients under the age of 18 were excluded.  Paediatric patients were not included because 
both SIRS criteria and qSOFA score were designed for use in the adult population.  
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3.6 Screening for sepsis 
 
Patients were screened for a Modified or Standardised Early Warning Score (MEWS or 
SEWS) of three or above using either electronic records or medical notes.  MEWS is the 
scoring system used at BHH (table 9), whilst SEWS is used at UHB (table 10). 
Both of these scoring systems are modified versions of the National Early Warning Score, 
which is endorsed by NHS England and produced by the Royal College of Physicians (25).   
Both scoring systems use a score of four or more to trigger escalation of care and 
consideration of sepsis.  This score was considered too high for screening purposes and 
would exclude patients with sepsis.  Pragmatically, a score of three or more was used, which 
is similar to the screening method used in a study by Szakmany et al (60).  A lower score 
than three was felt to be too onerous for data collection and would discourage participation 
in the audit.  Patients with a MEWS or SEWS score of three or above were further assessed 
for a high clinical suspicion of an infection (based upon clinical history, examination and 
investigations) by trained members of the audit team.  The SEWS score has been 
reproduced accurately and includes some difficulties in scoring correctly which occur on the 
real patient SEWS charts.  For example, it is unclear what score is given to a patient with a 
temperature of 35.8 as this falls in between a score of one or zero.  For instances where 
these ambiguities occurred in SEWS charts of the patients screened, the score was taken as 
that assigned by the patient’s medical team.  Patients with a high clinical suspicion of 
infection were further screened for sepsis using a modified SIRS criteria and the qSOFA 
criteria.  The modified SIRS criteria uses altered mental status and hyperglycaemia (plasma 
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glucose of more than 7.7 mM/l) in the absence of diabetes in addition to the original four 
parameters developed in 1991 (38).  The additional parameters are taken from the updated 
diagnostic criteria for sepsis developed in 2001 (39).  This modified SIRS criteria was used in 
a previous study on prevalence of sepsis in Wales (59).  Patients were deemed to have 
sepsis and were included for assessment of compliance with the sepsis six care bundle if 
they met either the modified SIRS criteria, or the qSOFA criteria.  Although qSOFA is meant 
as an identifier of patients at high risk of mortality from sepsis only, and should be followed 
with an assessment of the patient’s SOFA score, for pragmatic reasons patients were 
considered to have sepsis simply if they were qSOFA positive.   
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Table 9 Modified early warning score (MEWS), courtesy of Birmingham Heartlands 
Hospital 
Score 3 2 1 0 1 2 3 
Categories 
Respirations 
(breaths per 
minute) 
 8 
or 
less 
 9-16 17-20 21-29 30 or more 
Oxygen 
Saturations 
(%) 
   94 or 
more 
90-93 85-89 84 or less 
Systolic 
Blood 
Pressure 
(mmHg) 
70 
or 
less 
71-
80 
81-100 101-199  200 or 
more 
 
Pulse (beats 
per minute) 
   51-100 101-110 111-129 130 or more 
Conscious 
Level  
  New 
confusion/ 
agitation 
Alert Responds 
to Voice 
Responds 
to Pain 
Unresponsive 
Temperature  
(˚C) 
 35 
or 
less 
35.1-36 36.1-
37.5 
37.6-38.1 38.2 or 
more 
 
Urine (ml per 
hour) 
   No 
concerns 
21-35 1-20 Nil 
The modified early warning score (MEWS) is a simple aggregate scoring system based on 
seven physiological parameters recorded in routine practice in hospital.  A score is allocated 
to each parameter.  The magnitude of the score reflects how widely the parameter varies 
from normal physiological values.  mmHg = millimetres of mercury.  %= percentage.  °C = 
degrees Celsius. 
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Table 10 Standard early warning score (SEWS), courtesy of University Hospital Birmingham 
Score 3 2 1 0 1 2 3 
Category 
Heart Rate 
(beats per 
minute) 
<30 30-39 40-49 50-99 100-109 110-129 >130 
Systolic 
Blood 
Pressure 
(mmHg) 
 70-79 80-99 100-
199 
 >200  
Oxygen 
Saturations 
(%) 
<85 85-89 90-92 >93    
Respiratory 
Rate 
(breaths per 
minute) 
<9   9-20 20-30 31-35 >36 
Temperature 
(˚C) 
<34 34 35 36-37 >38 >39  
Conscious 
level 
   Alert  Responds 
to Voice 
Responds 
to Pain 
Unresponsive 
The standard early warning score (SEWS) is a simple aggregate scoring system based on six 
physiological parameters recorded in routine practice in hospital.  A score is allocated to 
each parameter.  The magnitude of the score reflects how widely the parameter varies from 
normal physiological values.  mmHg = millimetres of mercury.  %= percentage.  °C = degrees 
Celsius. 
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3.7 Assessing compliance 
 
For the purpose of the audit, time zero for implementing the sepsis six care bundle began 
when the MEWS or SEWS score was first recorded as three or more.  Compliance was 
defined as implementation of all six steps of the bundle within one hour.  Compliance to 
individual elements was also documented at one hour and at any time point up until time of 
data collection.  
3.8 The data collection team 
 
An independent team of investigators collected the data.  All members of the team were 
qualified doctors, ranging from foundation year to consultant, with training in medicine, 
emergency medicine or anaesthesia.  All the data collectors were recruited by asking for 
volunteers at educational meetings and via group e-mails to trainee junior doctors.  They 
were selected for the team if they were able to collect data during the time of the audit. As 
all members of the data collection team had a medical background, it was felt that they all 
had adequate training to recognise evidence of infection in patients and no extra training 
was given in this area.  The data collectors were asked to input “yes” to high clinical 
suspicion of infection if there was documentation of infection in the medical or nursing 
notes, or if in their own opinion there was a high clinical suspicion of infection based upon 
information in the medical or nursing notes.  Examples of this type of situation include a 
documentation of new onset of productive cough, dysuria with fever or a record of 
diarrhoea and vomiting.   
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Training was provided to all team members on aspects of data collection, including where to 
find the necessary information needed for the audit (e.g. patient charts, paper notes, 
electronic patient records) and how to use the electronic data collection device and toolkit.  
At UHB, this training took place one week before the audit took place and took 45 minutes.  
At BHH, this took place on the day of data collection and also took 45 minutes.  Further 
support for the data collectors occurred in real time via an electronic group messaging 
application.  At BHH, the main investigator (CF) was available to help any data collectors in 
person, but this was not required. 
3.9 Data collection 
 
Data were collected across the two hospitals via a secure open-source web-based toolkit on 
hand held electronic devices.  The devices and toolkit used to collect data were sourced 
from the Welsh Intensive Care Society.  It had originally been developed for use in a study 
by Szakmany et al (72), and was adapted for use in this audit.  The adaptation involved the 
removal of data entry that could identify individual patients (since this was an audit) and 
changes to the drop-down box list for name of hospital to UHB and BHH, rather than the list 
of Welsh hospitals used in the original study.  Ward areas were also updated to reflect the 
wards of UHB and BHH.  All other aspects of the toolkit were unchanged. The toolkit 
involved drop-down boxes for much of the data entry to minimise the chance of error and 
ensure data quality.  The computer operating system used included logic rules to limit 
progression through the toolkit until all mandatory information is entered by the data 
collector (72). The algorithm used by the toolkit meant that data collectors did not have to 
identify patients with sepsis themselves.  Instead, the toolkit identified a patient as having 
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sepsis if two or more modified SIRS or qSOFA criteria were met after each individual criteria 
was recorded on the toolkit by the data collector.  Free text data entry included error 
messages for values lying outside of possible values to minimise data entry errors.  All data 
entered were reviewed for errors by an investigator (CF).  Data were collected from patient 
observational charts, medical notes and electronic records as appropriate.  Data collected 
are listed in table 11. 
The data from the electronic devices was encrypted and encrypted data were entered 
automatically into an electronic database designed to handle the information.  Data security 
was maintained using industry level encryption during data transmission and by ensuring 
that data servers were protected by firewalls.  The electronic database is stored on a 
password-protected Heart of England NHS Foundation Trust computer.  Only those involved 
in the audit have access to the database.  No patient identifiable data were collected.  
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Table 11 Data collected for the audit 
Data Items Categories 
Age Free text 
Gender Male 
Female 
 
Patient’s ward area Medical assessment unit 
Surgical assessment unit 
General medical 
General surgical 
 
Medical Specialty Free text 
Hospital UHB 
BHH 
 
Admission Source Home 
Other Hospital 
Nursing home 
 
Time of observations Free text 
Highest MEWS/SEWS score between 00:00 and 
23:59 on 22nd June 2016 
Free text 
Comorbidities Diabetes 
Heart failure 
Hypertension 
Ischaemic heart disease 
Liver disease 
Recent chemotherapy 
Smoker 
Ex-smoker 
 
Drug history ACE-inhibitor 
Beta blocker 
Long term antibiotics 
Diuretics 
Immunosuppressant 
Insulin 
HMG-CoA reductase inhibitors 
Steroids 
 
Blood culture results (if taken) Free text 
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Data Items Categories 
Criteria used to confirm sepsis Modified SIRS 
qSOFA 
Both modified SIRS and qSOFA 
Laboratory values for white cell count, 
platelets, creatinine, bilirubin, lactate and 
glucose 
Free text 
Which elements of the sepsis six bundle were 
fulfilled and whether this was within 1 hour of 
time zero 
Yes 
No 
Whether the patient was seen by critical care 
outreach at any point 
Yes 
No 
Site of suspected infection Pulmonary 
Urinary tract 
Intra-abdominal 
Indwelling vascular device 
Other 
Source Unknown 
 
Antibiotics given Free text 
Whether a DNAR was in place Yes 
No 
 
Whether a ceiling of treatment plan was in 
place 
 
Yes 
No 
Whether a screening tool for sepsis was 
completed by the medical team 
 
Yes 
No 
Length of hospital stay Free text 
In-hospital, 30-, 60- and 90-day mortality Free text 
Table listing the data collected during the audit.  The toolkit involved drop down lists for 
gender, hospital, medical specialty, admission source, medical conditions, drug history, 
criteria used to confirm sepsis, elements of the sepsis six bundle fulfilled, critical care 
outreach involvement, ceiling of treatment and completion of screening tool.  Free text 
boxes displayed error messages for values outside of possible range.  MEWS = modified 
early warning score.  SEWS= standard early warning score.  DNAR = do not attempt 
resuscitation order.   
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3.10 Data analysis 
 
Data were analysed using Excel version 14.0.6112.5000, Microsoft, USA and SPSS Statistics 
version 23, IBM.  Descriptive statistics have been used as this was the most appropriate 
method for the audit data collected.  No sample size calculation was undertaken as the 
audit was a snapshot of compliance and sepsis prevalence rather than a study attempting to 
find out a specific comparative difference.  Data have been tested for normality using a 
Shapiro-Wilk test, a common test for normality that is appropriate for small sample sizes.  
Categorical variables are described using counts and percentage.  Measures for continuous 
variables are described using median and inter-quartile range (IQR) as they were not 
normally distributed.  Differences in categorical variables have been analysed using Fisher’s 
exact test due to the small sample size collected.  Statistical significance level has been set 
at P < 0.05 as is standard for scientific medical data. 
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4. RESULTS 
 
4.1 Implementing the data analysis plan 
 
The planned statistical methods were deemed to be applicable to the dataset collected, 
making descriptive statistics suitable as intended and the planned statistical tests 
appropriate.  The Shaprio-Wilk test confirmed that data were not normally distributed, and 
therefore median and inter-quartile range have been used for continuous variables, as 
intended.  The Fisher’s exact test was used as planned for the comparison of compliance 
rates between hospitals as the most appropriate statistical method for a small sample size. 
4.2 Patients screened and diagnosed with sepsis 
 
There were 249 acute adult admissions over the 24-hour study period and all of these 
patients were screened for suspected sepsis (figure 2).  Ninety-eight patients were screened 
at UHB, with ten (10.2%) having a SEWS score of three or more.  All ten patients who had a 
SEWS score of three or more (100%) met the diagnostic criteria for sepsis.  At BHH, 151 
patients were screened, with 17 (11.2%) having a MEWS score of three or above.  Of these, 
14 (82.4%) met the diagnostic criteria for sepsis as defined by the study (modified SIRS ≥ 2 
or qSOFA ≥ 2 plus infection).  Overall, 24 patients (9.6%) met the criteria for sepsis.  All 24 
patients (100%) met the modified SIRS diagnostic criteria for sepsis but only six (25%) had a 
qSOFA score of two or above, resulting in a prevalence of sepsis of 9.6% amongst new 
hospital admissions when the modified SIRS criteria is used, and a prevalence of 2.4% when 
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qSOFA criteria is used.  There were no patients who met the qSOFA criteria alone without 
also meeting the modified SIRS criteria for sepsis. 
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Figure 2 Audit flow diagram 
Diagram detailing the screening process of patients and flow of participants in the audit.  
BHH = Birmingham Heartlands Hospital.  UHB = University Hospital Birmingham.  MEWS = 
modified early warning score.  SEWS = standard early warning score.  SIRS = systemic 
inflammatory response syndrome (modified version).  qSOFA = quick sequential (sepsis 
related) organ failure assessment.   
Adapted from: Consort 2010 Flow Diagram.  Available at: http://www.consort-
statement.org/ (accessed 10th May 2018) 
  
58 
 
4.3 Patient demographics 
 
Patient demographics can be viewed in table 12.  The majority of patients were admitted 
from their homes (21 patients, 87.5%) and most patients were admitted under acute 
medicine (15 patients, 62.5%) with care being delivered on medical assessment units (MAU) 
(16 patients, 66.7%).  Patients had a wide range of comorbidities, most commonly diabetes 
(six patients, 25.0%), hypertension (seven patients, 29.2%) and hypercholesterolaemia 
(seven patients, 29.2%).  Patients were taking a variety of medications, most commonly 
diuretics (six patients, 25.0%) and HMG-CoA reductase inhibitors (seven patients, 29.2%).  
Two patients (8.33%) had a Do Not Attempt Resuscitation (DNAR) order and documented 
limitations on treatment.  
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Table 12 Patient demographics 
Patient Demographic Suspected Sepsis Patients 
Age median (interquartile range) 62 (47.8-77.5) 
Gender: male n (%) 14 (58.3) 
Admission Source n (%)  
Home 21 (87.5) 
Other Hospital 1 (4.17) 
Nursing Home 2 (8.33) 
Specialty n (%)  
Acute medicine 15 (62.5) 
General surgery 2 (8.33) 
Respiratory 2 (8.33) 
Cardiothoracic 2 (8.33) 
Other (oncology, stroke or endocrine) 3 (12.5) 
Ward n (%)  
Medical assessment unit 16 (66.7) 
Surgical assessment unit 1 (4.17) 
General medical 4 (16.7) 
General surgical 2 (8.33) 
Comorbidities n (%)  
Diabetes 6 (25.0) 
Heart failure 2 (8.33) 
Hypertension 7 (29.2) 
Ischaemic heart disease 4 (16.7) 
Liver disease 1 (4.17) 
Recent chemotherapy 2 (8.33) 
Smoker 4 (16.7) 
Ex-smoker 3 (12.5) 
Drug History n (%)  
ACE-inhibitor 3 (12.5) 
Beta blocker 2 (8.33) 
Long-term antibiotics 1 (4.17) 
Diuretics 6 (25.0) 
Immunosuppressant 2 (8.33) 
Insulin 4 (16.7) 
HMG-CoA reductase inhibitors 7 (29.2) 
Steroids 2 (8.33) 
DNAR n (%) 2 (8.70) 
Ceiling of treatment (ward) n (%) 2 (8.70) 
The demographics of patients assessed in the audit. n = number of patients.  ACE = 
angiotensin-converting enzyme.  HMG-CoA = 3-hydroxy-3-methyl-glutaryl-coenzyme A.  
DNAR = do not attempt resuscitation order. 
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4.4 Infection characteristics 
 
The most common modifed SIRS criteria that occurred in patients with suspected sepsis was 
a raised heart rate of more than 90 beats per minute (18 patients, 75%).  The most common 
qSOFA criteria that occurred was a respiratory rate of more than 22 breaths per minute (10 
patients, 41.7%) (table 13). 
The commonest suspected source of infection was pulmonary (10 patients, 41.7%), followed 
by urinary tract (three patients, 12.5%) and intra-abdominal (three patients, 12.5%).  Twenty 
patients (84%) were not diagnosed with sepsis by the admitting team, including three 
patients (12.5%) who were not identified by the admitting team with any form of infection.  
The median MEWS or SEWS scores was four (interquartile range three to five).  Fifteen 
patients had a MEWS or SEWS score of four or more, which mandates a review by critical 
care outreach as per hospital guidelines.  However, only one of these 15 patients (6.67%) 
was reviewed.  This patient had a SEWS score of four.  None of the patients were admitted 
to ICU or had any other critical care involvement.  
Eight patients had blood cultures taken and two of these (25%) were positive (Methicillin 
sensitive Staphylococcus aureus from one patient, Staphylococcus epidermidis and 
Actinomyces sp from another patient).  Both of these positive blood cultures were likely to 
be due to skin contaminants. 
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Table 13 Infection characteristics of patients with suspected sepsis 
Infection Characteristics Total Number of patients (%)  
Source of Sepsis   
Pulmonary 10 (41.7) 
Urinary tract 3 (12.5) 
Intra-abdominal 3 (12.5) 
Indwelling vascular device 2 (8.33) 
Other 2 (8.33) 
Source unknown 4 (16.7) 
Two or more modified SIRS Criteria Present  24 (100) 
Individual modified SIRS Criteria Present   
Temperature>38.3°C 8 (33.3) 
Temperature<36°C 3 (12.5) 
Altered mental state 7 (29.2) 
HR>90/minute 18 (75.0) 
RR>20/minute 13 (54.2) 
WCC>12,000/µL 15 (62.5) 
WCC<4000/µL 2 (8.30) 
Glucose>7.7mmol/L 7 (29.2) 
Two or more qSOFA Criteria Present 6 (25.0) 
Individual qSOFA Criteria Present   
RR>22/minute 10 (41.7) 
Altered mentation 7 (29.2) 
Systolic BP<100mmHg 7 (29.2) 
Sepsis screening tool completed 2 (8.33) 
Seen by Critical Care Outreach 1 (4.17) 
In-hospital Mortality 0 (0) 
 Median (interquartile range) 
MEWS/SEWS score  4 (3-5) 
Length of Stay in days  7.5 (3-12) 
The infection characteristics of patients assessed in the audit.  SIRS = systemic inflammatory 
response syndrome.  HR = heart rate.  RR= respiratory rate.  WCC = white cell count.  
Glucose = blood glucose level.  BP= blood pressure.  qSOFA = quick sequential (sepsis 
related) organ failure assessment.  MEWS = modified early warning score.  SEWS = standard 
early warning score. 
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4.4.1 MEWS and SEWS scores 
 
The MEWS and SEWS scores differ slightly in their parameter settings.  Therefore the potential SEWS 
scores of patients from BHH and the potential MEWS scores of patients from UHB were calculated to 
see if there would be a change in score depending upon the early warning score used.  Table 14 
shows the MEWS and SEWS score for each patient.  There were four patients from BHH who would 
only have scored two on the SEWS scoring system, meaning that if these patients had presented to 
UHB, they would not have been included in the audit.  All patients from UHB would have scored at 
least three on the MEWS chart used at BHH and would therefore have all been included in the audit 
if they had presented to BHH.  The MEWS scoring system tended to result in a higher score for most 
patients compared to the SEWS scoring system for most patients. 
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Table 14 Comparison of MEWS and SEWS scores for each patient audited 
Patient 
Number 
(BHH) 
MEWS 
score 
SEWS 
score 
Change in score (SEWS 
compared to MEWS)  
Would patient’s categorisation have 
changed if they had presented to UHB? 
1 5 4 -1 No 
2 5 3 -2 No 
3 5 4 -1 No 
4 3 2 -1 Yes: would not have been included in audit 
5 4 3 -1 No 
6 5 4 -1 No 
7 5 4 -1 No 
8 3 2 -1 Yes: would not have been included in audit 
9 4 4 0 No 
10 5 3 -2 No 
11 5 2 -3 Yes: would not have been included in audit 
12 3 2 -1 Yes: would not have been included in audit 
13 3 4 +1 No 
14 3 3 0 No 
Patient 
Number 
(UHB) 
MEWS 
score 
SEWS 
score 
Change in score (SEWS 
compared to MEWS) 
Would patient’s categorisation have 
changed if they had presented to BHH? 
15 3 4 +1 No 
16 3 3 0 No 
17 7 6 -1 No 
18 5 4 -1 No 
19 3 3 0 No 
20 4 3 -1 No 
21 5 4 -1 No 
22 4 3 -1 No 
23 6 4 -2 No 
24 5 4 -1 No 
The MEWS and SEWS scores of each patient included in the audit.  The change in score 
between SEWS compared to MEWS is listed for each patient and the impact this would have 
on categorisation is recorded.  BHH = Birmingham Heartlands Hospital.  UHB = University 
Hospital Birmingham. MEWS = modified early warning score.  SEWS = standard early 
warning score.   
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4.5 Observation characteristics 
 
The majority of patients had an abnormal respiratory rate (median 21 breaths per minute; 
interquartile range (IQR) 18-26) and tachycardia (median 106 beats per minute; IQR 92-119).  
Blood pressure was less likely to be abnormal (median systolic blood pressure 122mmHg; 
IQR 111-143 ) and most patients had a Glasgow coma score (GCS) of 15.  Most patients had 
a low grade temperature (median 37.5°C; IQR 36.4-38.2 ).  The median and interquartile 
range of patient’s observations can be seen in table 15.   
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Table 15 Observation characteristics of patients with suspected sepsis 
Observation Characteristics Suspected Sepsis Patients (n=24) 
Observation                        Median (interquartile range) 
Respiratory rate (breaths per minute) 21 (18-26) 
Oxygen saturations (%) 96 (92-98) 
Heart rate (beats per minute) 106 (92-119) 
Systolic blood pressure (mmHg) 122 (111-143) 
Diastolic blood pressure (mmHg) 65 (56-82) 
Temperature (°C) 37.5 (36.4-38.2) 
GCS 15 (15-15) 
The observation characeteristics of patients assessed in the audit.  n = number of patients.  
GCS = Glasgow coma score, ranges from 3-15; higher score indicates better neurological 
function.  
  
66 
 
4.6 Compliance with the sepsis six care bundle 
 
Overall, compliance with the sepsis six care bundle was low (table 16) with only one patient 
(4.17%) having all aspects completed.  For individual bundle elements, compliance was 
highest for intravenous fluids (14 patients, 58.3%) and intravenous antibiotics (14 patients, 
58.3%).  Compliance was lowest for measuring urine output (four patients, 16.7%).  For the 
four patients with sepsis diagnosed by the team responsible for medical management, none 
received all elements of the care bundle, although all four patients received intravenous 
antibiotics.  Three of the four patients diagnosed with sepsis by the admitting team were 
given intravenous fluids, two had blood cultures taken and one had a lactate measured.  
None were given oxygen and none had their urine output measured. 
Individual compliance rates at BHH and UHB is shown in table 17.  More patients at BHH 
received intravenous antibiotics and oxygen within one hour than at UHB; however this 
difference was not statistically significant.  Fewer patients at BHH had a lactate measured, 
blood cultures taken and urine output measured than patients at UHB, but only compliance 
to the measurement of lactate was statistically significantly higher at UHB.  The one patient 
who received all elements of the sepsis six care bundle was at UHB.  The overall rate of 
compliance with the bundle was not statistically significantly different between the two 
hospitals. 
  
67 
 
Table 16 Compliance with each element of the sepsis six care bundle 
Therapy Achieved within 1 hour n (%) Achieved at any point n (%) 
IV fluids 14 (58.3) 18 (75) 
IV antibiotics 14 (58.3) 19 (79.2) 
Oxygen 5 (20.8) 9 (37.5) 
Lactate measured 12 (50.0) 17 (70.8) 
Blood cultures taken 5 (20.8) 8 (33.3) 
Urine output 
measured 4 (16.7) 6 (25.0) 
All six 1 (4.17) 1 (4.17) 
Table of compliance with each element of the bundle as number of patients (n) who 
received each therapy and percentage of all patients who received each therapy.  IV = 
intravenous. 
 
 
 
Table 17 Compliance with each element of the sepsis six care bundle at each hospital 
Therapy Achieved within 1 hour Achieved at any point 
BHH n (%) UHB n (%) p value BHH n (%) UHB n (%) p value 
IV fluids 8 (57.1) 6 (60) 1.0000 10 (71.4) 7 (70) 1.0000 
IV antibiotics 9 (64.2) 5 (50) 0.6785 10 (71.4) 8 (80) 1.0000 
Oxygen 4 (28.6) 1 (10) 0.3577 5 (35.7) 4 (40) 1.0000 
Lactate measured 4 (28.6) 8 (80) 0.0361 7 (50.0) 10 (100) 0.0188 
Blood cultures 
taken 
2 (14.2) 3 (30) 0.6146 3 (21.4) 5 (50) 0.2038 
Urine output 
measured 
1 (7.14) 3 (30) 0.2721 2 (14.2) 4 (40) 0.1921 
All six 0  1 (10) 0.4167 0 1 (10) 0.4167 
Table demonstrating the compliance to each element of the sepsis six care bundle at each 
hospital.  n= number of patients who received the therapy.  BHH = Birmingham Heartlands 
Hospital.  UHB = University Hospital Birmingham. 
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4.7 Mortality and length of stay data 
 
No patients died during their hospital admission.  One (4.17%) died within 30 days of 
admission and a further two patients (8.33%) died within 60 days.  There were no further 
deaths up to 90 days.  All three patients who died were receiving palliative care for cancer.  
The median length of stay in hospital was 7.5 days (interquartile range 3-12 days).   
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5. DISCUSSION AND CONCLUSIONS 
 
5.1 Key findings 
 
5.1.1 Sepsis is common amongst new hospital admissions 
 
The results demonstrate that sepsis is a common problem, affecting nearly 10% of acute 
hospital admissions.  It is one of only a few audits or studies to measure sepsis prevalence in 
the general ward setting (49, 59, 60).  Previous studies on the prevalence of sepsis identified 
that 4.2%- 5.5% of in-patients had sepsis, depending on the clinical criteria used (59, 60).  
The higher prevalence found in this audit compared to previous findings may be due to the 
audit methodology; this audit only identified prevalence of sepsis in new acute hospital 
admissions, whereas the previous studies investigated the prevalence of sepsis amongst all 
hospital inpatients (59, 60).  Other studies on epidemiological data for sepsis estimate the 
incidence rather than prevalence of sepsis, making comparison difficult; a study of data 
from seven high-income countries demonstrated an incidence of hospital-treated sepsis of 
437 (95% CI 334-571) per 100,000 person-years and an incidence of severe sepsis of 270 
(95% CI 176-412) per 100,000 person-years (18).   
However, due to the methodology used for this audit, it is possible that the prevalence of 
sepsis has been underestimated.  Only screening patients with a MEWS or SEWS score of 
three or more for sepsis may have missed patients who had a lower MEWS or SEWS score, 
but still had sepsis.  This flaw in the audit methodology and the potential impact on the 
results is discussed further in section 5.3.  
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The most common source of sepsis in this audit was pulmonary, which correlates with 
studies that have identified this as the commonest source of infection in patients with sepsis 
presenting to hospital (20, 22, 60). 
 
5.1.2 The prevalence of sepsis differs depending on the criteria used  
 
In this audit, fewer patients had a positive qSOFA score than patients who met the modified 
SIRS criteria for sepsis, resulting in a prevalence of sepsis amongst new hospital admissions 
of 9.6% when the modified SIRS criteria is used, and 2.4% when the qSOFA score is used.  
This has also been demonstrated in a retrospective analysis of data from the USA: out of 
2593 patients admitted to ED or hospital with infection, 1526 met the SIRS criteria and 378 
met the qSOFA criteria, with overlap between the two (i.e. some patients met both criteria) 
(73).  The intention of qSOFA is to screen patients with infection and identify those who are 
at high risk of mortality (42).  This may explain why qSOFA identified fewer patients than the 
modified SIRS criteria; out of the three patients who died, two had a positive qSOFA score.   
5.1.3 The MEWS and SEWS scoring systems are not comparable 
 
An analysis of the MEWS and SEWS scoring systems demonstrated marked differences in 
scores for the same patient, with MEWS tending towards a higher score compared to SEWS.  
There were four patients at BHH who would have scored two on a SEWS chart at UHB; if 
they had presented to UHB they would not have been screened for sepsis and would not 
have been included in the audit.  Therefore it is likely that there were patients at UHB who 
scored 2 or less on the SEWS scoring system and therefore not included in the audit, who 
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would have had a MEWS score of three or more if they had been admitted to BHH, and 
subsequently included in the audit.  Unfortunately, due to the methodology used, it is not 
possible to find out how many patients with sepsis were potentially missed.  It is likely that 
the prevalence of sepsis has been underestimated as a result.  It also explains why there 
were less patients identified at UHB with sepsis than at BHH, despite UHB being the larger of 
the two hospitals.   
This has highlighted the discrepancies between different early warning systems in use across 
the UK.  Since December 2018, both UHB and BHH (who are now under one trust) use the 
NEWS 2 early warning score (table 18) (74).  NEWS 2 is the latest version of the National 
Early Warning Score, first produced in 2012 and updated December 2017.  It has been 
endorsed by NHS England and NHS improvement to be used as the early warning score for 
all acutely ill patients in hospitals in England.  This will allow standardisation across all NHS 
hospitals, avoiding situations like those highlighted by the audit where one scoring system 
would miss potentially sick patients compared to another.  Following implementation of 
NEWS 2 nationwide, further auditing and research in this area will be standardised 
throughout all NHS hospitals.  In addition to the implementation of NEWS 2, the national 
CQUIN indicator on reducing the impact of serious infections (antimicrobial resistance and 
sepsis) implemented in 2017 is likely to result in increased screening of sepsis and earlier 
administration of IV antibiotics to patients with sepsis due to the monetary incentive for 
trusts to complete these tasks (64).  Together, NEWS 2 and the sepsis CQUIN is likely to have 
a positive impact on sepsis recognition and management. 
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Table 18 The National Early Warning Score (NEWS) 2 
Physiological 
Parameter 
Score 
3 2 1 0 1 2 3 
Respiration Rate 
(per minute) 
≤ 8  9-11 12-20  21-24 ≥ 25 
SpO2 Scale 1 (%) ≤ 91 92-93 94-95 ≥ 96    
SpO2 Scale 2 (%) ≤ 83 84-85 86-87 88-92 
≥ 93 on 
air 
93-94 
on 
oxygen 
95-96 
on 
oxygen 
≥ 97 on 
oxygen 
Air or oxygen?  Oxygen  Air    
Systolic blood 
pressure (mmHg) 
\leg 
90 
91-100 101-
100 
111-
219 
  ≥ 220 
Pulse (per minute) ≤ 40  41-50 51-90 91-110 111-130 ≥ 131 
Consciousness    Alert   CVPU 
Temperature (°C) ≤ 
35.0 
 35.1-
36.0 
36.1-
38.0 
38.1-
39.0 
≥ 39.1  
 
The national early warning score (NEWS) 2 is a simple standardised aggregate scoring 
system based on six physiological parameters recorded in routine practice in hospital.  A 
score is allocated to each parameter.  The magnitude of the score reflects how widely the 
parameter varies from physiological values.  SpO2 = oxygen saturations.  % = percentage. 
mmHg = millimetres of mercury.  °C = degrees Celsius.  CVPU = Confusion, voice, pain, 
unresponsive.  Score for NEW onset of confusion (no score if chronic).  Use SpO2 scale 2 if 
target range is 88-92%, e.g. in hypercapnic respiratory failure. 
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5.1.4 Compliance with the sepsis six care bundle is low 
 
Despite the sepsis six care bundle being recommended for nearly a decade, compliance 
remains low.  This was demonstrated in both hospitals, suggesting that the problem is 
unlikely to be due to local factors affecting just one individual hospital.  Compliance for all 
elements of the bundle was lower in this audit (4.17%) compared to a previous study, which 
demonstrated an overall compliance level to the sepsis six care bundle of 12% (60).  The 
previous study was conducted in Wales, where there is a national public health campaign 
(1000 Lives Improvement) to reduce deaths and episodes of harm within NHS Wales 
through quality improvement programmes (60).   
The 1000 Lives Improvement service in Wales aims to achieve sustainable and measurable 
improvements in healthcare and includes initiatives to “support organisations in the early 
detection and prevention of acute deterioration” (75).   This has included enterprises to 
improve the management of sepsis across Wales and could explain the higher compliance 
rates in the study by Szakmany et al. (60).  All health boards and trusts within NHS Wales 
have actively participated in RRAILS (rapid response to acute illness learning set) (76).  The 
RRAILS steering group led to the introduction of NEWS in 2013 (four years before NHS 
England endorsed NEWS 2 for use in hospitals across England), sepsis screening and the 
sepsis six care bundle to all NHS hospitals across Wales.  This level of national 
standardisation and implementation of quality improvement standards is likely to have led 
to the higher compliance rates seen in the study by Szakmany et al (60).  Clinicians would be 
aware of the sepsis screening tool and sepsis six bundle even if they were new starters to 
the hospital as the implementation of this practice is across the whole of Wales.  It is 
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possible that following the introduction of NEWS 2 and the sepsis CQUIN in England that 
compliance rates will increase to be comparable with the rates reported by Szakmany et al 
(60).  
Compliance is much lower than when the sepsis six care bundle was initially implemented; 
compliance rates of 38.6% were demonstrated by Daniels et al. in an observational cohort 
study completed after the introduction of the sepsis six care bundle (22).  Other recent 
studies have also been unable to establish high compliance rates; two quality improvement 
projects in the UK and New Zealand had baseline compliance levels of 7% and 4% 
respectively (61, 62).   
Only four (16.7%) patients in this audit were diagnosed with sepsis by the admitting team, 
suggesting that lack of recognition of sepsis is one reason for poor compliance.  The 
discrepancy between the number of patients identified by the admitting team compared to 
the data collection team is likely to be a result of the data collection toolkit.  The toolkit 
involved an algorithm that would work out which patients had sepsis based upon whether 
they fulfilled two or more of the modified SIRS or qSOFA criteria.  The data collection team 
did not have to work out whether a patient had sepsis themselves, they simply inputted 
each patient parameter for the diagnostic criteria for modified SIRS or sepsis into the toolkit.  
In contrast, the admitting team did not have access to the toolkit and computerised 
algorithm, so would have had to diagnose sepsis themselves.  It is likely that without the 
toolkit aiding them, the data collectors would have missed patients with sepsis as well.  This 
highlights the potential advantages of computer-based early warning systems that may pick 
up acutely ill patients, including those with sepsis, that clinicians may miss. 
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However, even the patients specifically labelled by the medical team as having sepsis were 
not managed as per the sepsis six care bundle.  It is reassuring to see that compliance is 
highest for giving intravenous antibiotics and fluids, arguably the more important elements 
of the sepsis six care bundle, as demonstrated by recent studies that have shown survival 
benefit with early antibiotics and intravenous fluid bolus (65-68).  Compliance for these 
parts of the bundle were higher than those achieved in a previous study (IV antibiotics 
compliance: 58.3% in this audit vs. 40% (sepsis) and 54% (severe sepsis) in study by 
Szakmany et al.  IV fluids compliance: 58.3% in this audit vs. 22% (sepsis) and 34% (severe 
sepsis) in study by Szakmany et al.), but lower than the compliance levels in the study by 
Daniels et al. (IV antibiotic compliance 61.6% and IV fluids compliance 67.7%) (22, 60).  The 
higher rates of compliance for IV antibiotics and fluids suggests awareness amongst 
clinicians of the importance of these aspects of the care bundle.  In contrast, oxygen was 
only administered to five patients within one hour of sepsis diagnosis, which could be due to 
clinician awareness of the potential detrimental effects of hyperoxia (63).  There is limited 
evidence to suggest that measurement of urine output and lactate and taking blood cultures 
leads to improvements in patient survival from sepsis.  The Surviving Sepsis Campaign’s 
international guidelines for the management of sepsis and septic shock advises routine 
microbiological cultures should be obtained prior to the commencement of antimicrobial 
therapy as a best practice statement only (52).  The measurement of lactate is only 
recommended by the Surviving Sepsis Campaign in the context of guiding resuscitation to 
normalise lactate in patients with elevated lactate levels.  This was graded as a weak 
recommendation with low quality of evidence (52).  Urine output is used as a marker of 
illness severity and tissue hypoperfusion and can be used in conjunction with other 
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physiological variables, such as heart rate, blood pressure and respiratory rate to evaluate a 
patient’s response to treatment (52).  However, the Surviving Sepsis Campaign advocates 
the use of dynamic variables to predict fluid responsiveness, such as passive leg raises or 
fluid challenges against stroke volume measurements, rather than static variables such as 
urine output (52).  Clinicians who are aware of these guidelines and the lack of evidence 
relating to these components of the sepsis six bundle may have made a conscious decision 
to omit these parts of the bundle when managing their patients. 
It is also possible that in addition to the questionable efficacy of some elements of the care 
bundle, the clinical team may have felt that the interventions were inappropriate due to the 
lack of illness severity in many of the patients.  The average MEWS or SEWS score was four, 
and median observation characteristics were all within normal ranges other than respiratory 
rate (21 breaths per minute) and heart rate (106 beats per minute).  Therefore, given the 
mildness of illness in the patients in this audit, the omission of elements of the sepsis six 
bundle may have been deliberate. 
Other reasons for poor compliance with the sepsis six care bundle include issues such as 
quick turnover of medical staff who are not familiar with the care bundle.  Junior doctors in 
NHS hospitals can rotate up to every three months, and therefore may have come from 
trusts that put less emphasis on the sepsis six bundle for the management of patients with 
sepsis.  Other doctors may have recently relocated from hospitals abroad where the sepsis 
six bundle is not used.  As discussed earlier, this could explain the higher compliance rates in 
the study by Szakmany et al, where the sepsis six bundle has been implemented and 
promoted in every NHS hospital in Wales (60).   
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Another common problem with compliance to any care bundle is the lack of senior doctor 
involvement.  A quality improvement project in an emergency department in the UK found 
that lack of prompt senior involvement led to uncertainty in management decisions and a 
delay in implementation of the sepsis six bundle (77).  It is junior staff who perform the 
majority of initial medical assessments and therefore inexperience, lack of knowledge and 
slow decision making is likely to impact on compliance levels with the sepsis six bundle (77). 
Poor communication and practical barriers are further reasons for poor compliance, as 
demonstrated by an ethnographic study of the implementation of the sepsis six bundle (70). 
Delays in implementation resulted from doctors failing to communicate with nurses 
(resulting in delays in IV antibiotic administration), difficulty in coordinating multiple tasks 
(such as finding someone IV trained to administer antibiotics whilst also managing the care 
of other patients) and operational failures such as a lack of equipment for lactate 
measurement (70).  It is likely that many of these same factors influenced compliance in this 
audit, particularly lack of communication with nurses who would be administering 
antibiotics and fluids, and managing the care of multiple patients at once, leading to delays. 
 
Improving compliance to care bundles can be difficult because of the multiple factors 
involved.  Studies on compliance to care bundles which have used a single intervention to 
improve compliance have had limited success.  A study aiming to improve compliance to a 
ventilator associated pneumonia (VAP) care bundle found that education alone was not 
enough to improve compliance (78).  A further study examining audit and feedback to 
improve compliance to a VAP bundle demonstrated a non-significant improvement in 
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overall compliance, and individual aspects of compliance to the bundle had in some 
instances worsened (79).  
Quality improvement projects focussing on increasing compliance to the sepsis six bundle 
have been moderately successful when using a multifactorial approach.  Several projects 
have used a combination of education, checklists and stickers, sepsis “champions” and 
sepsis “packs” (61, 62, 80).  These combinations of interventions have improved compliance, 
but are labour intensive and require sustained implementation to work. 
A systematic analysis of the effect of performance improvement programmes on 
compliance with sepsis bundles found that education and process change can successfully 
improve compliance and showed a concomitant reduction in mortality (81).  Quality 
improvement initiatives in Brazil have reduced hospital mortality from sepsis; however this 
reduction in mortality resulted from earlier recognition of sepsis, rather than increased 
compliance to a six-hour sepsis bundle (82). 
Lack of compliance to the sepsis six care bundle, difficulties in improving compliance and the 
absence of evidence of a survival benefit all call into question the suitability of the sepsis six 
bundle for use in the modern healthcare setting.  As discussed in chapter one, there is much 
controversy surrounding the use of the sepsis six care bundle and it’s supposed efficacy (53).  
The sepsis six care bundle was developed to improve compliance to the Surviving Sepsis 
Campaign’s 6-hour resuscitation bundle (22).  The six elements of the sepsis six bundle were 
identified from those that were found to be poorly performed in an initial gap analysis (22).  
Therefore, the sepsis six care bundle did not originate from evidence-based medicine but 
was developed to improve compliance to another bundle (22).  The 6-hour resuscitation 
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bundle involved EGDT, which has since been found to have no survival benefit compared to 
standard care (54-58).  The sepsis six care bundle has not been validated for use; it’s 
widespread implementation was based upon the findings from one observational cohort 
study by the designers of the bundle (22).  The limitations of the observational cohort study 
and the lack of reproducibility of the results have been discussed in chapter one, and the 
findings of poor compliance and low mortality rates in this audit further question the use of 
the sepsis six care bundle. 
5.1.5 Mortality rates are lower than reported 
 
Despite the poor compliance to the sepsis six care bundle, mortality within 90 days of 
admission was low at 12.5% and all three deaths were cancer related.  This is lower than the 
mortality rates found in previous studies: one study demonstrated a 90-day mortality rate of 
29% for sepsis and 35% for severe sepsis, whereas another study in Brazil found that 
mortality rates varied between 33.3% and 58.3% for different institutions. (60, 82).  A 
retrospective study of data from seven high-income countries measured hospital mortality 
rates at 17% for sepsis and 26% for severe sepsis; the study included data from 1979 to 
2015 so it is likely that the higher mortality rates reflect the inclusion of mortality reports 
from earlier decades (18).  The lower mortality rate demonstrated by this audit may reflect 
the severity of sepsis for this cohort of patients; the average MEWS score was 4, suggesting 
that these patients may have had less severe illness than patient cohorts in other studies 
(60).   
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5.2 Strengths of the audit 
 
The audit met its primary aim and objective, which was to assess compliance with the sepsis 
six care bundle in two acute NHS trusts in the West Midlands and compare compliance 
between the two trusts. The novel use of hand-held electronic devices to collect data for the 
audit allowed quick data collection and instant upload.  This saved time replicating data 
collected on paper data collection forms and allowed for standardisation of data collection.  
The toolkit can be easily adapted for use in other audits or studies (72).  Another strong 
point of this audit was the rigorous training of the data collectors in the use of the data 
collection tool, along with an online group messaging service for real-time data collection 
support, ensuring data collection quality. Data were prospectively collected, allowing real-
life utilisation and comparison of the new qSOFA score with the modified SIRS criteria for 
sepsis in the clinical setting.  Using the modified SIRS criteria rather than the original four-
parameter SIRS criteria will have reduced the likelihood of missing patients with sepsis and 
involved the most up to date version of the SIRS criteria.  None of the patients were lost to 
follow up, providing a complete dataset for analysis.   
5.3 Limitations of the audit 
 
There are limitations to this audit.  Due to the small number of patients involved, it was not 
possible to assess the effect of compliance to the sepsis six bundle on mortality rates, 
meaning that this aim and objective of the audit was not met.  Furthermore, due to the 
pragmatic screening method used (only those with a MEWS or SEWS score of three or above 
were screened for sepsis) it is likely that there were patients with sepsis that were missed, 
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introducing bias into the audit results.  Using either the SEWS or MEWS scoring system, it is 
possible to meet the modified SIRS criteria of sepsis with a score of zero.  This could happen 
if a patient had a heart rate of 95 beats per minute and a white cell count of 14000/mm3.  It 
is also possible to meet the qSOFA criteria for sepsis with a MEWS score of 2 (e.g. altered 
mental state and systolic blood pressure of 100mmHg) or a SEWS score of 1 (e.g. respiratory 
rate of 25 breaths per minute and systolic blood pressure of 100mmHg).  This may mean 
that the prevalence of sepsis found in this study is an underestimate of the true prevalence 
of sepsis amongst new hospital admissions.  As a result of this introduced bias, the second 
aim and objective of the study may not have been met accurately.  However, the prevalence 
found in this audit was higher than that found in other studies, suggesting a higher rate of 
recognition of sepsis in this audit compared to previous studies, despite the methodology 
used.  The distribution of source of infection closely correlates with those found in previous 
studies, suggesting that the screening method did not bias for or against any subgroup of 
patients based upon source of infection (20,22,60).    
This screening method was used to avoid a labour intensive data collection process and to 
encourage site participation.  It was a pragmatic approach based upon the methodology 
used in a previous study (59), and it was felt that the small proportion of patients that may 
be missed as a result would be acceptable in light of increased site participation.  However, 
due to the resulting small number of patients included in the audit, it would be beneficial to 
change the methodology to screen all patients for sepsis regardless of MEWS or SEWS score 
in any future audits. 
The audit was designed to provide a snapshot of the management of patients with 
suspected sepsis and involved a small number of patients over a short time period.  Only 
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new hospital admissions were included in the audit, missing patients who had been 
inpatients for more than 24 hours who had developed sepsis whilst in hospital.  The 
management of these patients is likely to be different from those acutely admitted with 
sepsis; Daniels et al. found that compliance to the sepsis six care bundle was much higher in 
the emergency department compared to the wards (22).  This could be due to increased 
awareness amongst acute clinicians of sepsis and its management, as well as the masking of 
signs and symptoms of developing sepsis on the ward due to concurrent illnesses.  The small 
number of patients makes it difficult to generalise the results, and the short time period 
means that it is likely to be the same group of clinicians caring for all the patients included in 
the audit and therefore only the management skills of a small cohort of clinicians will have 
been scrutinised.  It is possible that performing the audit on another day, at an alternative 
time of the year, with a different set of clinicians could have yielded different results.   
5.6 Recommendations 
 
Sepsis prevalence appears to be higher than previously estimated, and it is likely that the 
findings from this audit have still underestimated the rates of sepsis.  Establishing an 
accurate rate of sepsis prevalence is needed to understand the full impact of sepsis on the 
UK population. 
Focussing on improving compliance to the sepsis six care bundle may not improve patient 
outcomes.  Instead, management of sepsis should focus on recognising those at highest risk 
of death from sepsis and targeting individualised care to these patients.  The new NICE 
guidelines on sepsis management and the NEWS 2 early warning score have been designed 
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to enable earlier recognition of sick patients with sepsis and future research will establish 
the impact of NICE and NEWS 2 on sepsis management. 
 Although research has established the validity of the SEPSIS-3 definitions in patients 
admitted to ICU, debate remains over the best way to recognise those at highest risk of 
sepsis on the wards and further research is needed to validate scoring systems used to 
identify high risk of mortality from sepsis in ward patients, including the use of NEWS 2 to 
identify those patients at high risk of death from sepsis (83).   
Research is now recommended in the following key areas, in light of the project findings: 
1. What is the true prevalence of sepsis in all hospital patients, including acute 
admissions and inpatients? 
2. Has the implementation of NEWS 2 increased clinician recognition of sepsis? 
3. Has the implementation of NICE guidelines in the UK improved patient mortality 
from sepsis? 
4. Should SIRS or the SOFA and qSOFA score or NEWS 2 be used in the UK to identify 
patients at risk of mortality from sepsis in the ward setting? 
The true prevalence of sepsis should be established through a national database that 
records all patients who meet the diagnostic criteria for sepsis as defined by SEPSIS-3.  
Although a significant undertaking, the success of other large national audit databases, such 
as the National Emergency Laparotomy Audit (NELA), the Intensive Care National Audit and 
Research Centre (ICNARC), the National Confidential Enquiry into Patient Outcome and 
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Death (NCEPOD) and Mothers and Babies: Reducing Risk through Audits and Confidential 
Enquiries across the UK (MBRRACE-UK), suggest that it is feasible. 
The second and third questions may be answered by studying the compliance of healthcare 
providers to NICE guidelines on recognition, diagnosis and early management of sepsis to 
evaluate uptake of the guidance by clinicians and to establish the rate of recognition of 
sepsis amongst clinicians following the implementation of NEWS 2.  A review of mortality 
and outcomes following this evaluation would then assess the efficacy of the new NICE 
guidelines. 
The fourth question may be answered by conducting a prospective observational study in 
the UK to compare the mortality rates of general ward patients identified with sepsis using 
SIRS, SOFA, qSOFA and NEWS-2. 
Answering these research questions will establish the true prevalence of sepsis, result in 
validated criteria for identifying patients at high risk of death from sepsis in the UK ward 
setting and establish the best practice for sepsis management, leading to improved 
outcomes for patients. 
5.7 Conclusion 
 
Sepsis continues to be a common condition with significantly high mortality rates, despite 
advances in our understanding of the pathophysiology and management of sepsis.  This is 
due to its heterogeneous nature, making the diagnosis and management of sepsis 
challenging.  This audit has highlighted both of these issues, demonstrating that the 
prevalence of sepsis will change dependent upon the criteria used to classify sepsis, and 
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that compliance to the sepsis six care bundle remains low.  However, the impact of these 
issues on patient mortality cannot be demonstrated by this audit.  Future research should 
focus on the ability of sepsis classifications to identify those at high risk of death and the 
impact of new sepsis management guidelines on patient outcomes.  
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